This is a Validated Antibody Database (VAD) review about human CD3E, based on 921 published articles (read how Labome selects the articles), using CD3E antibody in all methods. It is aimed to help Labome visitors find the most suited CD3E antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD3E synonym: IMD18; T3E; TCRE

BioLegend
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, 317330) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:1000; loading ...
BioLegend CD3E antibody (Biolegend, 317318) was used in flow cytometry on human samples at 1:1000. J Hematol Oncol (2022) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse
BioLegend CD3E antibody (BioLegend, OCT3) was used in flow cytometry on mouse samples . Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s2e
BioLegend CD3E antibody (Biolegend, 344840) was used in flow cytometry on human samples (fig s2e). Nat Commun (2022) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 3b). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (Biolegend, 300306) was used in flow cytometry on human samples (fig s1). Front Med (Lausanne) (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3b
BioLegend CD3E antibody (BioLegend, 300452) was used in flow cytometry on human samples (fig s3b). Sci Adv (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig s1
BioLegend CD3E antibody (Biolegend, HiT3A) was used in flow cytometry on human samples (fig s1). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig 1b). Oncoimmunology (2022) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig s12c
BioLegend CD3E antibody (BioLegend, 300327) was used in flow cytometry on human samples (fig s12c). Cell Rep Med (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 6a
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 6a). J Neuroinflammation (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1f, s1b
BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples (fig 1f, s1b). MBio (2022) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...; fig s4a
BioLegend CD3E antibody (Biolegend, 300443) was used in mass cytometry on human samples (fig s4a). Biomark Res (2022) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD3E antibody (Biolegend, 317334) was used in flow cytometry on human samples (fig 1c). Biomark Res (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:50; fig s4b
BioLegend CD3E antibody (BioLegend, 300452) was used in flow cytometry on human samples at 1:50 (fig s4b). Cells (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 1a). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 4d
BioLegend CD3E antibody (Biolegend, 317326) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 4d). J Immunother Cancer (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 6d
BioLegend CD3E antibody (Biolegend, 300306) was used in flow cytometry on human samples (fig 6d). Nat Commun (2022) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:100; fig 4d, s7
BioLegend CD3E antibody (BioLegend, 317334) was used in flow cytometry on human samples at 1:100 (fig 4d, s7). Sci Transl Med (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD3E antibody (BioLegend, 300305) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (BioLegend, HIT3A) was used in flow cytometry on human samples . Sci Adv (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . Front Immunol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; 1:100; loading ...; fig 1e
BioLegend CD3E antibody (Biolegend, 300459) was used in flow cytometry on mouse samples at 1:100 (fig 1e). Front Immunol (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on mouse samples (fig s1a). J Immunother Cancer (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 5:100; loading ...; fig 4a
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples at 5:100 (fig 4a). Nat Commun (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 6c, 6f
BioLegend CD3E antibody (BioLegend, 300430) was used in flow cytometry on human samples at 1:100 (fig 6c, 6f). Nat Commun (2021) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 1,000 ug/ml; fig 4h
BioLegend CD3E antibody (BioLegend, 300314) was used in blocking or activating experiments on human samples at 1,000 ug/ml (fig 4h). J Immunother Cancer (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:50; loading ...; fig s4
BioLegend CD3E antibody (BioLegend, 300406) was used in flow cytometry on human samples at 1:50 (fig s4). Nat Med (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD3E antibody (Biolegend, 317302) was used in flow cytometry on human samples (fig 5e). Cell (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD3E antibody (Biolegend, 344816) was used in flow cytometry on human samples (fig 5e). Cell (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD3E antibody (Biolegend, 344816) was used in flow cytometry on human samples (fig 5e). elife (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD3E antibody (Biolegend, 344816) was used in flow cytometry on human samples (fig 5e). Front Cell Infect Microbiol (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD3E antibody (Biolegend, 344816) was used in flow cytometry on human samples (fig 5e). Nature (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Front Immunol (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig 2b). Cancers (Basel) (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse; 1:1000; loading ...
BioLegend CD3E antibody (Biolegend, 317329) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:400; loading ...
BioLegend CD3E antibody (BioLegend, 300324) was used in flow cytometry on human samples at 1:400. Cell (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, 300440) was used in flow cytometry on human samples (fig 1a). Cell Host Microbe (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, 317331) was used in flow cytometry on human samples (fig 1a). Cell Host Microbe (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD3E antibody (Biolegend, 317332) was used in flow cytometry on human samples at 1:100. Immunity (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:50
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples at 1:50. Nature (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 5). Arthritis Res Ther (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, 344813) was used in flow cytometry on human samples . Aging (Albany NY) (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD3E antibody (Biolegend, 344818) was used in flow cytometry on human samples (fig s2). Mucosal Immunol (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 2
BioLegend CD3E antibody (BioLegend, HIT3A) was used in flow cytometry on human samples (fig 2). Aging Cell (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD3E antibody (Biolegend, 317343) was used in flow cytometry on human samples (fig s1b). BMC Biol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s4d
BioLegend CD3E antibody (Biolegend, 300402) was used in flow cytometry on human samples (fig s4d). Science (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD3E antibody (BioLegend, 300448) was used in flow cytometry on human samples (fig s1b). Immunity (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend CD3E antibody (BioLegend, 300311) was used in flow cytometry on mouse samples (fig 8a). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (BioLegend, 300420) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD3E antibody (BioLegend, 317328) was used in flow cytometry on human samples (fig 4c). Sci Transl Med (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, 344834) was used in flow cytometry on human samples . Science (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (BioLegend, 317347) was used in flow cytometry on human samples . Science (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend CD3E antibody (BioLegend, 317324) was used in flow cytometry on mouse samples (fig 2). J Autoimmun (2021) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 1c
BioLegend CD3E antibody (Biolegend, 300454) was used in immunohistochemistry on mouse samples at 1:50 (fig 1c). J Autoimmun (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:1000; loading ...; fig s1d
BioLegend CD3E antibody (Biolegend, 300425) was used in flow cytometry on human samples at 1:1000 (fig s1d). Cell (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:100
BioLegend CD3E antibody (Biolegend, 300318) was used in flow cytometry on human samples at 1:100. Science (2021) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1c, s11
BioLegend CD3E antibody (Biolegend, 300408) was used in flow cytometry on human samples (fig s1c, s11). Sci Rep (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s2a
BioLegend CD3E antibody (Biolegend, 317324) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s6-2
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig s6-2). elife (2020) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 5a, 5c
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 5a, 5c). J Clin Invest (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples (fig 1). BMC Res Notes (2020) ncbi
mouse monoclonal (OKT3)
  • other; mouse
BioLegend CD3E antibody (BioLegend, OKT3) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, 300412) was used in flow cytometry on human samples . Nat Commun (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD3E antibody (BioLegend, UCHT-1) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2020) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1s3b
BioLegend CD3E antibody (Biolegend, 317320) was used in flow cytometry on human samples (fig 1s3b). elife (2020) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:2000; loading ...; fig 2j
BioLegend CD3E antibody (BioLegend, 300316) was used in flow cytometry on human samples at 1:2000 (fig 2j). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig s3a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig s3a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:25; loading ...
BioLegend CD3E antibody (Biolegend, 300436) was used in flow cytometry on human samples at 1:25. bioRxiv (2020) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD3E antibody (Biolegend, 317340) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2s5a
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 7s1b, 7s1c
BioLegend CD3E antibody (BioLegend, 317313) was used in flow cytometry on human samples (fig 7s1b, 7s1c). elife (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 3:50; loading ...; fig 3j
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples at 3:50 (fig 3j). Science (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s12a
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig s12a). Nat Commun (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD3E antibody (BioLegend, 300406) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:200; loading ...; fig 7a
BioLegend CD3E antibody (BioLegend, 300418) was used in flow cytometry on human samples at 1:200 (fig 7a). elife (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD3E antibody (Biolegend, 300430) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; loading ...; fig e9i
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on mouse samples (fig e9i). Nature (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 7s1a
BioLegend CD3E antibody (Biolegend, 300448) was used in flow cytometry on human samples at 1:100 (fig 7s1a). elife (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s14b
BioLegend CD3E antibody (Biolegend, Hit3a) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s6c
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig e4f
BioLegend CD3E antibody (Biolegend, 300403) was used in flow cytometry on human samples at 1:100 (fig e4f). Nature (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:250; loading ...; fig 6c
BioLegend CD3E antibody (BioLegend, 300405) was used in flow cytometry on human samples at 1:250 (fig 6c). Nat Commun (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CD3E antibody (Biolegend, 300402) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3s2a
BioLegend CD3E antibody (Biolegend, 300454) was used in flow cytometry on human samples (fig 3s2a). elife (2019) ncbi
mouse monoclonal (HIT3a)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 7d, 7f
BioLegend CD3E antibody (BioLegend, HIT3a) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 7d, 7f). J Clin Invest (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, 300420) was used in flow cytometry on human samples (fig 1a). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend CD3E antibody (BioLegend, 300412) was used in flow cytometry on mouse samples (fig s5b). Nat Immunol (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:200; fig s7a
BioLegend CD3E antibody (Biolegend, 300424) was used in flow cytometry on human samples at 1:200 (fig s7a). Nat Commun (2019) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, UCHT1) was used in mass cytometry on human samples . PLoS Pathog (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig s1). J Immunol (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s2o
BioLegend CD3E antibody (Biolegend, 317324) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:200; loading ...; fig 2a
  • immunocytochemistry; human; 1:200; fig 2h
BioLegend CD3E antibody (Biolegend, 300415) was used in flow cytometry on human samples at 1:200 (fig 2a) and in immunocytochemistry on human samples at 1:200 (fig 2h). elife (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD3E antibody (BioLegend, 300425) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:100; loading ...; fig s10a
BioLegend CD3E antibody (Biolegend, 344816) was used in flow cytometry on human samples at 1:100 (fig s10a). Nat Commun (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD3E antibody (Biolegend, 300448) was used in flow cytometry on human samples (fig s3c). Cancer Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • other; human; loading ...; fig 4b
BioLegend CD3E antibody (BioLegend, 300475) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD3E antibody (BioLegend, 300308) was used in flow cytometry on human samples (fig 4a). Diagn Pathol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD3E antibody (BioLegend, 344822) was used in flow cytometry on human samples (fig 2a). Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD3E antibody (BioLegend, 300435) was used in flow cytometry on human samples (tbl 1). J Exp Med (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD3E antibody (Biolegend, 300402) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD3E antibody (BioLegend, HiT3A) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig s1c, s2a
BioLegend CD3E antibody (Biolegend, 300410) was used in flow cytometry on human samples at 1:100 (fig s1c, s2a). Cancer Cell (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:100; loading ...; fig s1a, s3b
BioLegend CD3E antibody (Biolegend, 317328) was used in flow cytometry on human samples at 1:100 (fig s1a, s3b). Cancer Cell (2019) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 5 ug/ml; loading ...; fig s10e
BioLegend CD3E antibody (Biolegend, OKT3) was used in blocking or activating experiments on human samples at 5 ug/ml (fig s10e). Nature (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, 300420) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD3E antibody (Biolegend, 300324) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s1). Front Immunol (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:1; fig s4
BioLegend CD3E antibody (BioLegend, 317330) was used in flow cytometry on human samples at 1:1 (fig s4). Nat Commun (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 9d
BioLegend CD3E antibody (BioLegend, 300312) was used in flow cytometry on human samples (fig 9d). J Exp Med (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s7a
BioLegend CD3E antibody (BioLegend, 300460) was used in flow cytometry on human samples (fig s7a). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 2a
  • immunocytochemistry; human; fig 2d
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 2a) and in immunocytochemistry on human samples (fig 2d). Cell Stem Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, 300406) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 4a). Front Immunol (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 1). Am J Transplant (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse; loading ...; fig s14a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on mouse samples (fig s14a). J Clin Invest (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig s3c). Transl Oncol (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s5
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig s5). Front Immunol (2018) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 8f
BioLegend CD3E antibody (BioLegend, OKT3) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 8f). J Clin Invest (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD3E antibody (BioLegend, 300424) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples at 1:100. Nature (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s1c). J Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD3E antibody (Biolegend, 317328) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, HIT3a) was used in blocking or activating experiments on human samples (fig 1a). Eur J Immunol (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, 317329) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, 300319) was used in flow cytometry on human samples (fig 1a). Cell Rep (2018) ncbi
mouse monoclonal (OKT3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6d
BioLegend CD3E antibody (Biolegend, OKT3) was used in immunohistochemistry - paraffin section on human samples (fig 6d). Cancer Res (2018) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig 6a
BioLegend CD3E antibody (BioLegend, OKT3) was used in blocking or activating experiments on human samples (fig 6a). FASEB J (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig s4a). J Clin Invest (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 2a). J Immunol (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig 2c). Nat Immunol (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig 1a). Int J Infect Dis (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 7d
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 7d). J Biol Chem (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 7a
BioLegend CD3E antibody (BioLegend, 300439) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig e1b
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig e1b). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 2e). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig 2e). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD3E antibody (BioLegend, 300429) was used in flow cytometry on human samples (fig 6c). Immunity (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD3E antibody (BioLegend, 300316) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; loading ...; fig 2c
BioLegend CD3E antibody (Biolegend, UCHT1) was used in blocking or activating experiments on human samples (fig 2c). Oncotarget (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend CD3E antibody (biolegend, SK7) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s1). J Exp Med (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (Biolegend, 300406) was used in flow cytometry on human samples (fig 1a). F1000Res (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples . Cancer Res (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5a
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 5a). Cancer Res (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (Biolegend, 344814) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (Biolegend, 300318) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 5a). FEBS Lett (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1a
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to investigate the fecal microbiomes of HIV-uninfected to HIV-infected individuals on long-term antiretroviral therapy, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 3d
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 3d). Clin Exp Immunol (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig s1a). JCI Insight (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig s3a). Sci Rep (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4a
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BioLegend CD3E antibody (Biolegend, 300434) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 2a
  • flow cytometry; human; fig 2a
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, BioLegend CD3E antibody (Biolegend, OKT3) was used in blocking or activating experiments on human samples (fig 2a) and in flow cytometry on human samples (fig 2a). Leukemia (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 4b). J Virol (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a method to assess the capacity of human regulatory T cells to suppress IgM production from an immature human B cell line, BioLegend CD3E antibody (Biolegend, 317306) was used in flow cytometry on human samples (fig 1a). J Immunol Methods (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig s4a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD3E antibody (BioLegend, Okt3) was used in blocking or activating experiments on human samples (fig s4a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BioLegend CD3E antibody (Biolegend, 300424) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HIT3a)
  • immunocytochemistry; human; loading ...; fig s9
BioLegend CD3E antibody (BioLegend, HIT3a) was used in immunocytochemistry on human samples (fig s9). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...
BioLegend CD3E antibody (BioLegend, OKT3) was used in blocking or activating experiments on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig s7
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD3E antibody (Biolegend, 317332) was used in flow cytometry on human samples (fig s7). Cell (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 5a
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 5a). Clin Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4b
In order to analyze the capacity of monocytes, neutrophils, and CD4 T cells to serve as accessory cells for gamma delta T cell activation, BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 4b). J Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 7a
BioLegend CD3E antibody (BioLegend, 300317) was used in flow cytometry on human samples (fig 7a). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig s5
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig s6a). J Clin Invest (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CD3E antibody (Biolegend, 300329) was used in flow cytometry on human samples (fig s5a). Sci Rep (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 1
In order to examine the interaction between Trichomonas vaginalis and human immune cells, BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples (fig 1). PLoS Negl Trop Dis (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BioLegend CD3E antibody (Biolegend, 317328) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s2a
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig s2a). Eur J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 2a
In order to generate a T-cell receptor-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex and test it in preclinical models of acute myeloid leukemia, BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig 2a). Cytotherapy (2016) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; loading ...
In order to generate a T-cell receptor-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex and test it in preclinical models of acute myeloid leukemia, BioLegend CD3E antibody (BioLegend, HIT3a) was used in blocking or activating experiments on human samples . Cytotherapy (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2
In order to utilize flow cytometry to analyze intracellular Ca(2+) mobilization in human NK cell subsets, BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 2
BioLegend CD3E antibody (BioLegend, HIT-3a) was used in flow cytometry on human samples (fig 2). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (OKT3)
In order to research the drive of early signaling and vesicle dynamics during T-cell activation by Aurora A, BioLegend CD3E antibody (Biolegend, 317302) was used . Nat Commun (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1d
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples (fig 1b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:100; fig 5
BioLegend CD3E antibody (Biolegend, 300305) was used in flow cytometry on human samples at 1:100 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (UCHT1)
BioLegend CD3E antibody (Biolegend, 300440) was used . Sci Rep (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1d
In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend CD3E antibody (biolegend, HIT3a) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . Am J Transplant (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100. PLoS ONE (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend CD3E antibody (BioLegend, 300318) was used in flow cytometry on human samples . Haematologica (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; fig 3
BioLegend CD3E antibody (Biolegend, 3000316) was used in flow cytometry on mouse samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig st1
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BioLegend CD3E antibody (Biolegend, 300310) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; 1:100
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4a
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig 4a). Arthritis Res Ther (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BioLegend CD3E antibody (BioLegend, 344827) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 4b
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend CD3E antibody (BioLegend, 300317) was used in flow cytometry on human samples (fig 4b). J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
BioLegend CD3E antibody (BioLegend, 300418) was used . PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 8b
BioLegend CD3E antibody (Biolegend, 300406) was used in flow cytometry on human samples (fig 8b). PLoS ONE (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; mouse
In order to study immune escape from CD8+ T cell killing mediated by PD-L1 expression on retrovirus-infected cells, BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 4). Leukemia (2016) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry - frozen section; human; 1:50; fig 6
In order to determine how induced arthritis can be effectively treated by CTRP6, BioLegend CD3E antibody (Biolegend, 344802) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
BioLegend CD3E antibody (Biolegend, 300434) was used in flow cytometry on human samples (fig 1). Allergy (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study the relationship between HIV infection and the innate immune system, BioLegend CD3E antibody (Biolegend, 300417) was used in flow cytometry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, 300330) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, 300420) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; tbl 2
BioLegend CD3E antibody (Biolegend, 300312) was used in flow cytometry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 2
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 2). J Hematol Oncol (2015) ncbi
mouse monoclonal (UCHT1)
In order to elucidate the mechanism by which IFN-beta1b suppresses relapsing-remitting multiple sclerosis, BioLegend CD3E antibody (Biolegend, UCHT1) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; fig s3
BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples at 1:200 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200
In order to develop a system to determine human DC development and differentiation, BioLegend CD3E antibody (Biolegend, OKT) was used in flow cytometry on human samples at 1:200. J Immunol Methods (2015) ncbi
mouse monoclonal (OKT3)
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD3E antibody (biolegend, 317323) was used . PLoS Pathog (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3
BioLegend CD3E antibody (Biolegend, # 300431) was used in flow cytometry on human samples (fig 3). Biomaterials (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 3
In order to evaluate the therapeutic potential of a gammatheta T cell-targeting tribody for tumor immunotherapy, BioLegend CD3E antibody (Biolegend, #344826) was used in flow cytometry on human samples (fig 3). Cell Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3,4,5
BioLegend CD3E antibody (Biolegend, 300431) was used in flow cytometry on human samples (fig 3,4,5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig s7
In order to analyze multidrug resistant human cancer cells and autocrime cytokine/JAK/STAT-signaling induces kynurenin synthesis, BioLegend CD3E antibody (BioLegend, OKT3) was used in blocking or activating experiments on human samples (fig s7). PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend CD3E antibody (Biolegend, clone UCHT1) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, #300425) was used in flow cytometry on human samples . Immunol Invest (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, 317306) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, 344808) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, 300317) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4
BioLegend CD3E antibody (Biolegend, UCH1) was used in flow cytometry on human samples (fig 4). Infect Immun (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to evaluate the potency of program death ligand 1 and 2-silenced dendritic cell vaccines for ex vivo priming and in vivo boosting of minor histocompatibility antigen-specific CD8 positive T cell responses, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 2:100; fig 7
BioLegend CD3E antibody (BioLegend, UCHT1) was used in blocking or activating experiments on human samples at 2:100 (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples (fig 4). J Exp Med (2015) ncbi
mouse monoclonal (SK7)
  • immunocytochemistry; human; loading ...; fig 8a
In order to demonstrate a role for the actin network in regulating LFA-1 activity in T cells, BioLegend CD3E antibody (BioLegend, SK7) was used in immunocytochemistry on human samples (fig 8a). J Cell Biol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, OKT3) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig s3
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on human samples (fig s3). Blood (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend CD3E antibody (Biolegend, HIT3a) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
BioLegend CD3E antibody (BioLegend, OKT3) was used in blocking or activating experiments on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD3E antibody (Biolegend, 300431) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 3S
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD3E antibody (Biolegend, 300316) was used in flow cytometry on human samples (fig 3S). PLoS Pathog (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, SK7) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 0.5 ug/ml
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples at 0.5 ug/ml. Sci Rep (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; mouse; fig 1
BioLegend CD3E antibody (Biolegend, SK7) was used in flow cytometry on mouse samples (fig 1). Leukemia (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BioLegend CD3E antibody (BioLegend, HIT3a) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
BioLegend CD3E antibody (Biolegend, clone OKT3) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BioLegend CD3E antibody (BioLegend, HIT3a) was used in blocking or activating experiments on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
In order to study NK function in solid tumors, BioLegend CD3E antibody (Biolegend, OKT3) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, BioLegend CD3E antibody (BioLegend, UCHT-1) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • chromatin immunoprecipitation; human
  • western blot; human; fig 4a
BioLegend CD3E antibody (BioLegend, UCHT-1) was used in chromatin immunoprecipitation on human samples and in western blot on human samples (fig 4a). J Immunol (2013) ncbi
Invitrogen
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200
Invitrogen CD3E antibody (eBioscience, 48-0037-42) was used in flow cytometry on human samples at 1:200. Life Sci Alliance (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...
Invitrogen CD3E antibody (Thermo Fisher Scientific, RM-9107-S) was used in immunohistochemistry on mouse samples . Nat Commun (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5d
Invitrogen CD3E antibody (Epredia Labvision, RM9107R7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5d). Cell Mol Gastroenterol Hepatol (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; rat; 1:500; loading ...; fig 5c
Invitrogen CD3E antibody (Thermo Fisher, MA1-90582) was used in immunohistochemistry - frozen section on rat samples at 1:500 (fig 5c). Sci Rep (2022) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 5d
Invitrogen CD3E antibody (Thermo Fisher, 45-0036-42) was used in flow cytometry on human samples (fig 5d). J Biol Chem (2022) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 7h
Invitrogen CD3E antibody (Thermo Fisher, 14-0038) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 7h). J Exp Med (2022) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.25 ug/ml; loading ...; fig 5d
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.25 ug/ml (fig 5d). Oncoimmunology (2022) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml; loading ...; fig 4b
Invitrogen CD3E antibody (eBioscience, 16-0037) was used in blocking or activating experiments on human samples at 2 ug/ml (fig 4b). J Immunother Cancer (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3c
Invitrogen CD3E antibody (THERMOFISHER, MA5-14,524) was used in immunohistochemistry on mouse samples at 1:500 (fig 3c). Sci Rep (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 3b
Invitrogen CD3E antibody (ThermoScientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 3b). J Inflamm Res (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; loading ...; fig s3a
Invitrogen CD3E antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples at 1:200 (fig s3a). Nature (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:40; loading ...
Invitrogen CD3E antibody (ThermoFisher Scientific, 45-0037-42) was used in flow cytometry on human samples at 1:40. elife (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; loading ...; fig 1d
Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples at 1:100 (fig 1d). Neuropathol Appl Neurobiol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5b
Invitrogen CD3E antibody (Thermo Fisher Scientific, UCHT1) was used in flow cytometry on human samples (fig 5b). ACS Synth Biol (2021) ncbi
mouse monoclonal (UCHT1)
  • other; human; loading ...; fig s4-1e
Invitrogen CD3E antibody (Thermo Fisher Scientific, 16-0038-85) was used in other on human samples (fig s4-1e). elife (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD3E antibody (eBioscience, UCHT-1) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD3E antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples (fig s3). Nature (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; fig e4a
Invitrogen CD3E antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples at 1:200 (fig e4a). Nature (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:20; fig s11
Invitrogen CD3E antibody (Thermo Fisher Scientific, SK7) was used in flow cytometry on human samples at 1:20 (fig s11). Science (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig e1j
Invitrogen CD3E antibody (Thermo Fischer, RM-9107-S1) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig e1j). EMBO Rep (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
Invitrogen CD3E antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 4). Aging Cell (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6c
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 6c). Cell Death Dis (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
Invitrogen CD3E antibody (Invitrogen, 11-0036-42) was used in flow cytometry on human samples . Cancer Sci (2021) ncbi
mouse monoclonal (UCHT1)
  • western blot; human; 1:50; loading ...; fig s8a
Invitrogen CD3E antibody (Thermo Fisher, 56-0038-42) was used in western blot on human samples at 1:50 (fig s8a). Science (2020) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 1:50; loading ...; fig 1s3b
Invitrogen CD3E antibody (Thermo Fisher Scientific, MHCD0304) was used in flow cytometry on human samples at 1:50 (fig 1s3b). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD3E antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; mouse; fig 3e
Invitrogen CD3E antibody (ThermoFisher Scientific, F7.2.38) was used in immunohistochemistry on mouse samples (fig 3e). Nat Commun (2020) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 7j
Invitrogen CD3E antibody (Invitrogen, 7D6) was used in flow cytometry on human samples (fig 7j). J Exp Med (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3s1
Invitrogen CD3E antibody (eBioscience, 11-0038-42) was used in flow cytometry on human samples (fig 3s1). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
Invitrogen CD3E antibody (eBioscience, 15003842) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1c
Invitrogen CD3E antibody (eBioscience, 48-0037-41) was used in flow cytometry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD3E antibody (eBioscience, 17-0036-42) was used in flow cytometry on human samples (fig s1a). BMC Cancer (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3f, 3g
Invitrogen CD3E antibody (Invitrogen, SK7) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml; loading ...; fig 4a
Invitrogen CD3E antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples at 2 ug/ml (fig 4a). Diagn Pathol (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Invitrogen CD3E antibody (Invitrogen, 47-0037-41) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; loading ...; fig 2s1b
Invitrogen CD3E antibody (eBioscience, 45-0037-71) was used in flow cytometry on human samples at 1:200 (fig 2s1b). elife (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b
Invitrogen CD3E antibody (Themo, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b). elife (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig s4a
Invitrogen CD3E antibody (Thermofisher, MA1-90582) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig s4a). Cancer Cell (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3E antibody (eBioscience, 45-0036) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2a
Invitrogen CD3E antibody (Life Technologies, UCHT1) was used in flow cytometry on human samples (fig s2a). Nat Med (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s18b
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig s18b). Science (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:20; loading ...; fig 2m
Invitrogen CD3E antibody (Thermo Fisher, SP7) was used in immunohistochemistry on mouse samples at 1:20 (fig 2m). J Exp Med (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3i
Invitrogen CD3E antibody (eBiosciences, 13-0037-82) was used in flow cytometry on human samples (fig s3i). Cell (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD3E antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (fig s4a). Sci Immunol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Invitrogen CD3E antibody (Thermo Fisher Scientific, Sp7) was used in immunohistochemistry - paraffin section on human samples (fig 3b). J Clin Invest (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
Invitrogen CD3E antibody (ThermoFisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Cell (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, Invitrogen CD3E antibody (ebioscience, 16-0037) was used in flow cytometry on human samples (fig 2c). Cell Death Dis (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD3E antibody (Life Technologies, MHCD0301) was used in flow cytometry on mouse samples (fig 3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; loading ...; fig s1
Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD3E antibody (eBioscience, 11-0037-42) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD3E antibody (eBioscience, 13-0038-82) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 6d
Invitrogen CD3E antibody (ebioscience, OKT3) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 6d). PLoS ONE (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:200; loading ...; fig 4a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Invitrogen CD3E antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples at 1:200 (fig 4a). Front Immunol (2017) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human; loading ...; fig 1e
Invitrogen CD3E antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Invitrogen CD3E antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (tbl 1). Cell (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3a
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, Invitrogen CD3E antibody (eBioscience, 48-0038-42) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig s9
In order to find neoantigens in human mantle-cell lymphomas using samples from human patients, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig s9). Nature (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3e
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD3E antibody (Thermo Fisher Scientific, 48-0038) was used in flow cytometry on human samples (fig 3e). Cell Res (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD3E antibody (Thermo Fisher Scientific, 11-0039) was used in flow cytometry on human samples (fig 3a). Cell Res (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 4b
In order to study the differentiation of innate lymphoid cells, Invitrogen CD3E antibody (eBioscience, 11-0038) was used in flow cytometry on human samples (fig 4b). Cell (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD3E antibody (eBioscience, OKT-3) was used in flow cytometry on human samples (fig 2a). Oncoimmunology (2017) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...; fig 2a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, Invitrogen CD3E antibody (Thermo Fischer, CD3-12) was used in immunohistochemistry - frozen section on rhesus macaque samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Med Princ Pract (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 5
In order to employ ChIP-seq to analyze PAX8-PPARG fusion protein binding sites in a PAX8-PPARG fusion protein follicular thyroid carcinoma mouse model, Invitrogen CD3E antibody (Thermo Fischer Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 5). Oncotarget (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, Invitrogen CD3E antibody (Invitrogen, 7D6) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...; fig s1b
In order to use transgenic mice to assess the effects of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, Invitrogen CD3E antibody (ThermoFisher, RM9107) was used in immunohistochemistry on mouse samples (fig s1b). PLoS ONE (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen CD3E antibody (ebioscience, HIT3a) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT3)
  • immunocytochemistry; human; tbl 1
In order to discuss methods to visualize gangliosides involved in CD4 positive T cell activation, Invitrogen CD3E antibody (eBioscience, 16-0037-81) was used in immunocytochemistry on human samples (tbl 1). J Vis Exp (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen CD3E antibody (eBiosciences, OKT3) was used in flow cytometry on human samples (fig 2c). PLoS Pathog (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, Invitrogen CD3E antibody (eBioscience, UCHT1) was used . Leukemia (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, Invitrogen CD3E antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the role of Eomes in the retention of liver natural killer cells, Invitrogen CD3E antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Glia (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; human; 1:150; loading ...; fig 2b
In order to use MALDI-TOF-MS imaging to study immune cells in colon cancer samples, Invitrogen CD3E antibody (Thermo-Fisher, SP7) was used in immunohistochemistry - frozen section on human samples at 1:150 (fig 2b). J Proteome Res (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
In order to clarify the B cell-intrinsic functions of c-REL and RELA, Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, Invitrogen CD3E antibody (Invitrogen, 7D6) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
In order to study immune cells infiltration and renal injury in CCL5 KO mice., Invitrogen CD3E antibody (Laboratory Vision, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). Am J Pathol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Cancer Res (2017) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used . AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2.5 ug/ml; loading ...; fig 7d
In order to find that internal membrane reservoirs in T lymphocytes are recruited, likely through exocytosis, to induce large active deformations, Invitrogen CD3E antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples at 2.5 ug/ml (fig 7d). Mol Biol Cell (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 6a
In order to develop a method to quantify both the spatial distribution of a protein and its colocalization status, Invitrogen CD3E antibody (eBiosciences, 16-0037) was used in blocking or activating experiments on human samples (fig 6a). Mol Biol Cell (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3E antibody (eBioscience, 16-0037) was used in blocking or activating experiments on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human; loading ...
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, Invitrogen CD3E antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples . Cell Death Dis (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples . elife (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the density and distribution of tumor-infiltrating lymphocytes and tertiary lymphoid structures in pulmonary metastases from primary colorectal cancer and correlate them with clinicopathological variables, Invitrogen CD3E antibody (Thermo Fisher, RM9107-S1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Exp Metastasis (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, Invitrogen CD3E antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig s3a
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD3E antibody (eBiosciences, UCHT1) was used in blocking or activating experiments on human samples at 1 ug/ml (fig s3a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used . PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the reversal of renal injury and high blood pressure by renal rescue of dopamine D2 receptor function, Invitrogen CD3E antibody (Thermo Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry; human; 1:200; loading ...; fig 5d
In order to develop methods to study aberrant crypt foci, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in immunohistochemistry on human samples at 1:200 (fig 5d). Mol Cancer Res (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2). J Transl Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1c
In order to report that human CD11c positive cells are the main VEGF-A-producing cell population in reactive secondary lymphoid organs, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1c). Oncotarget (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig S1
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig S1). Sci Rep (2016) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, Invitrogen CD3E antibody (Life Technologies, UCHT1) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s3). PLoS ONE (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig s2a
  • immunohistochemistry - paraffin section; human; fig 4b
In order to investigate if ectopic expression of CX3CR1 enhances the homing of adoptively transferred T cells towards CX3CL1-producing tumors, resulting in increased T cell infiltration in tumor tissues, Invitrogen CD3E antibody (eBioscience, EB16-0037-85) was used in blocking or activating experiments on human samples (fig s2a) and in immunohistochemistry - paraffin section on human samples (fig 4b). J Immunother Cancer (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to characterize B and T cells from patients with thrombocytopenia, Invitrogen CD3E antibody (Invitrogen, CD0330) was used in flow cytometry on human samples . Haematologica (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2b
In order to assess the impact of phospholipase C gamma 2 mutations to the development of gastric mucosa-associated lymphoid tissue lymphomas, Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2b). PLoS ONE (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, 48-0038-42) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
domestic rabbit monoclonal (SP7)
  • flow cytometry; mouse; 1:150; loading ...; fig 4
In order to test whether heat-killed Staphyloccocus aureus inhibits the development of atherosclerosis, Invitrogen CD3E antibody (Thermo Fischer Scientific, SP7) was used in flow cytometry on mouse samples at 1:150 (fig 4). J Intern Med (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 8
Invitrogen CD3E antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (fig 8). J Exp Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to determine the role of fibroblast growth factor 21 (FGF21) in protecting from iselt hyperplasia and high fat diet induced inflammation in the pancreas, Invitrogen CD3E antibody (Thermo Scientific, MA1-90582) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:200; fig 4
In order to study murine experimental autoimmune encephalomyelitisto find a method for the histopathological study of the multifocal nature of spinal cord lesions, Invitrogen CD3E antibody (Neomarkers, RM-9107-5) was used in immunohistochemistry on mouse samples at 1:200 (fig 4). Peerj (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4b
In order to discuss models of squamous lung tumors to test therapeutic regimens, Invitrogen CD3E antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4b). J Thorac Oncol (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
Invitrogen CD3E antibody (eBioscience, OKT-3) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (SP7)
  • western blot; rat; 1:100; fig 13
In order to investigate the molecular mechanisms that regulate cardiomyocyte necroptosis, Invitrogen CD3E antibody (Thermo Scientific, RM9107) was used in western blot on rat samples at 1:100 (fig 13). Nat Med (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen CD3E antibody (eBioscience, UCHT1) was used . Immunol Res (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 2
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, Invitrogen CD3E antibody (eBioscence, 16-0037-85) was used in blocking or activating experiments on human samples (fig 2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to study nontuberculous mycobacterial infection with mutual IgG4-related lymphadenopathy, Invitrogen CD3E antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). APMIS (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to compare multiple sclerosis to autoimmune encephalitis in humans, Invitrogen CD3E antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...
In order to demonstrate that TGF-beta induces the differentiation of human CXCL13-producing CD4 positive T cells from naive CD4 positive T cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Eur J Immunol (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, Invitrogen CD3E antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
In order to study the localization and function of CXCR2 in hepatocellular carcinoma, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). J Exp Clin Cancer Res (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3
Invitrogen CD3E antibody (Tonbo, 25-0038) was used in flow cytometry on human samples (fig 3). Nat Commun (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
Invitrogen CD3E antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Nat Med (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 7
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • ELISA; human; fig 2
In order to characterize a bispecific scFv antibody targeting of human melanoma made in transgenic cattle called r28M, Invitrogen CD3E antibody (eBioscience, 16?C0039) was used in ELISA on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig e3d
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig e3d). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig e3d
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD3E antibody (eBioscience, (HIT3A) was used in flow cytometry on human samples (fig e3d). J Allergy Clin Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:250; tbl 1
In order to elucidate the prognosis of gastric cancer by tumor-infiltrating immune cells, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:250 (tbl 1). Medicine (Baltimore) (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3E antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (fig 1). MAbs (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD3E antibody (eBiosciences, SK7) was used in flow cytometry on human samples . Respir Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
In order to determine the effects of PD-0360324, a fully human immunoglobulin G2 monoclonal antibody against macrophage colony-stimulating factor, in patients with cutaneous lupus erythematosus, Invitrogen CD3E antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Clin Exp Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, Invitrogen CD3E antibody (Invitrogen, Q10054) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; fig 6c
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 6c). Nat Immunol (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig s5
In order to study how conformational changes control T cell receptor association and activity of Zap70, Invitrogen CD3E antibody (eBiosciences, 16-0037) was used in blocking or activating experiments on human samples (fig s5). Nat Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 2a). Kidney Int (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
In order to determine the periluminal distribution of CD4+ HIV target cells, Invitrogen CD3E antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig s1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4a
In order to determine the expression and function of HLA-G, HLA-G-regulatory microRNAs and the immune cell infiltration in renal cell carcinoma samples, Invitrogen CD3E antibody (Thermo Scientific, MA1?C90582) was used in immunohistochemistry on human samples (fig 4a). Oncoimmunology (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1b
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD3E antibody (eBioscience, HIT3A) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to investigate the role of VAMP8 in exocytosis, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 4). J Cell Biol (2015) ncbi
mouse monoclonal (MEM-57)
  • immunohistochemistry; human; 1:200
In order to characterize placental gastrokine 2 expression in the placenta, Invitrogen CD3E antibody (Thermo Scientific, MA1-19454) was used in immunohistochemistry on human samples at 1:200. Histochem Cell Biol (2015) ncbi
domestic rabbit polyclonal
In order to describe the pathophysiology of canine diabetes, Invitrogen CD3E antibody (Life Technologies, PA1-37282) was used . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human
Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, 48-0037-42) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.01 ug/ml; fig 1
In order to discuss how to use induced-pluripotent stem cells to generate neuron-like cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.01 ug/ml (fig 1). J Chin Med Assoc (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Nat Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:100
Invitrogen CD3E antibody (Lab Vision/NeoMarkers, SP7) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 7.5 ug/ml; loading ...; fig 6a
In order to develop an image analysis workflow to assess mouse colon cancer, Invitrogen CD3E antibody (Thermo Scientific, RM-9107-S) was used in immunohistochemistry - paraffin section on mouse samples at 7.5 ug/ml (fig 6a). Vet Pathol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4h
In order to identify a MCF2L variant linked to cardiovascular disease, Invitrogen CD3E antibody (ThermoFischer, SP7) was used in immunohistochemistry on human samples (fig 4h). Eur J Hum Genet (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 1
In order to study the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis, Invitrogen CD3E antibody (Thermo Fisher Scientific, SP-7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
In order to assess intrahepatic delivery of anti-CEA chimeric antigen receptor-modified T cells through percutaneous hepatic artery infusions, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1b). Clin Cancer Res (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 5 ug/ml
In order to study dysregulation of CD62L expression during HIV infection, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 5 ug/ml. J Virol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunoprecipitation; mouse
  • immunohistochemistry; human
Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunoprecipitation on mouse samples and in immunohistochemistry on human samples . Dig Dis Sci (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen CD3E antibody (Lab Vision, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; fig 3
In order to analyze the effects of tumor growth and spread in two murine models with monocolonal antibodies to oncofetal antigen- an immature laminin receptor protein, Invitrogen CD3E antibody (Thermo Scientific, RM9107-s) was used in immunohistochemistry on mouse samples (fig 3). Cancer Biol Ther (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen CD3E antibody (eBioscience, 48-0038) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s3a
In order to study the role of STAT3 in KRAS mutant lung adenocarcinoma., Invitrogen CD3E antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples at 1:100 (fig s3a). Nat Commun (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples (tbl 1). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (tbl 1). J Immunol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 3
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig 3). Cancer Immunol Res (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, Invitrogen CD3E antibody (Invitrogen, MHCD0306) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...
In order to demonstrate a role for the actin network in regulating LFA-1 activity in T cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Cell Biol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:25; loading ...; fig 2d
In order to study the effect of topical tenofovir gel in the rectal mucosa and primary vaginal cells., Invitrogen CD3E antibody (Thermo Fisher Scientific, RM9107S) was used in immunohistochemistry on human samples at 1:25 (fig 2d). elife (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, Invitrogen CD3E antibody (NeoMarkers, RM 9107) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.5 ug/ml
Invitrogen CD3E antibody (eBIoscience, OKT3) was used in blocking or activating experiments on human samples at 0.5 ug/ml. J Biol Chem (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - free floating section; human
Invitrogen CD3E antibody (Lab Vision, SP7) was used in immunohistochemistry - free floating section on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; mouse; 1:2000
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD3E antibody (Invitrogen, S4.1PB) was used in flow cytometry on mouse samples at 1:2000. Stem Cell Res (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150
Invitrogen CD3E antibody (Thermo Scientific Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150. J Am Acad Dermatol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 6g
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 6g). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (e-Bioscience, SK7) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
Invitrogen CD3E antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 2 ug/ml. PLoS Negl Trop Dis (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150
Invitrogen CD3E antibody (THERMO SC., SP7) was used in immunohistochemistry on human samples at 1:150. BMC Clin Pathol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). J Exp Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 0.05 ug/ml
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples at 0.05 ug/ml. J Leukoc Biol (2014) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Immunobiology (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
In order to study the cell mediated immune response to JCV T-Ag in patients with colorectal adenomatous polyps or cancers, Invitrogen CD3E antibody (eBioscience, 45-0037-42) was used in flow cytometry on human samples . Gut Microbes (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to study the relations between neurodegeneration, demyelination, inflammation, and iron in regards to multiple sclerosis, Invitrogen CD3E antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000. J Neurol Neurosurg Psychiatry (2014) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the role of gammadeltaT cells during human ischemic stroke, Invitrogen CD3E antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBiosciences, OKT3) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to explore the protective mechanism by which the oxysterol receptors suppress inflammatory bowel disease, Invitrogen CD3E antibody (Labvision, RM-9107-S0) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Mucosal Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen CD3E antibody (Fisher/Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (e-Biosciences, OKT-3) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human
In order to study virus-specific human memory T-cell activation in response to Dribble-mediated cross-presentation of viral antigens, Invitrogen CD3E antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples . J Transl Med (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used . PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • immunocytochemistry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen CD3E antibody (eBioscience, UCHT1) was used in immunocytochemistry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen CD3E antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Circ Arrhythm Electrophysiol (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, 14-0037-82) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen CD3E antibody (Labvision/Thermo Scientific, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunocytochemistry; human; 1:100
Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunocytochemistry on human samples at 1:100. J Crohns Colitis (2014) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 3 ug/ml
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 3 ug/ml. J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study CD161 high CD8+ T cells in an HIV and Mycobacterium tuberculosis endemic African setting., Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to examine the effect on cellular iron uptake upon expression of the accessory protein Nef from different lentiviral strains, Invitrogen CD3E antibody (Caltag, UCHT1) was used in flow cytometry on human samples . Retrovirology (2014) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human
In order to test the effect of different Mycobacterium tuberculosis molecules on HIV-1 replication, Invitrogen CD3E antibody (Ebioscience, UCHT1) was used in blocking or activating experiments on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 0.5 ug/ml; fig 1
Invitrogen CD3E antibody (eBioscience, HIT3a) was used in blocking or activating experiments on human samples at 0.5 ug/ml (fig 1). Ann Rheum Dis (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen CD3E antibody (eBioscience, UCHT1) was used . J Infect Dis (2014) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to use zinc-finger nucleases to simultaneous modify ccr5 and cxcr4 in primary human CD4(+) T cells and introduce these cells into a humanized mouse model of HIV-1 infection, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Blood (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to test if the epileptogenic mechanisms underlying Rasmussen encephalitis are related to changes in ADK expression, Invitrogen CD3E antibody (Lab Vision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). J Neuropathol Exp Neurol (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study iNKT cells and A2ARs in sickle cell disease, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human
  • western blot; human; fig 5
In order to explore how EBV infection influences CMV-driven immune differentiation, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in blocking or activating experiments on human samples and in western blot on human samples (fig 5). J Virol (2013) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . Ann Rheum Dis (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to characterize T cells after MVA85A vaccination, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to investigate the mechanisms that lead to demyelination and neurodegeneration, Invitrogen CD3E antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Brain (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify the cause of an autosomal recessive syndrome, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . J Med Genet (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to determine cytokine profiles of CD4(+) T-helper (h) cells in adults and young children vaccinated with the antigens PspA, PcpA, PhtD, PhtE, Ply, LytB of Streptococcus pneumonia and protein D and OMP26 of non-typeable Haemophilus influenza, Invitrogen CD3E antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (fig 1). Vaccine (2013) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to study facilitation of HIV-1 transmission to cervico-vaginal tissue ex vivo by interleukin-7, Invitrogen CD3E antibody (Invitrogen, noca) was used in flow cytometry on human samples . PLoS Pathog (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD3E antibody (Invitrogen, clone S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to assess the effects of trichosanthin treatment, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 4). J Investig Allergol Clin Immunol (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to report results from a phase 1 trial testing the A2AR agonist regadenoson in adults with sickle cell disease, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Blood (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study assembly of the T cell antigen receptor, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . BMC Immunol (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to discuss how Epstein-Barr virus contributes to the development of small B-cell neoplasms, Invitrogen CD3E antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). PLoS ONE (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD3E antibody (CALTAG, MHCD0305) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:50; fig s3
In order to report that TNFR1-independent prion accumulation in lymph nodes depends on LTbetaR signaling, Invitrogen CD3E antibody (Thermoscientific, RM-9107-S1) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3). PLoS Pathog (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to determine the function and phenotypes of antigen-specific CD4(+) T cells in adults compared to infants upon acellular pertussis vaccine administration, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . Clin Exp Immunol (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 2
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD3E antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (fig 2). Vaccine (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to identify surrogates of anti-tumor immune responsiveness after DC vaccination, Invitrogen CD3E antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 4). PLoS ONE (2012) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; fig 5
In order to analyze the proliferation and functional profile of circulating double positive T cells from acutely HIV-infected individuals and chronically HIV-infected viral controllers, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 5). J Immunol (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; fig 1
In order to test if damage to the lymphoid tissue fibroblastic reticular cell network contributes to naive T cell loss during HIV-1 infection, Invitrogen CD3E antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:100 (fig 1). PLoS Pathog (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse
In order to characterize mammary cancers in multiparous Stat1 knockout mice, Invitrogen CD3E antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples . Oncotarget (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 2
In order to evaluate the prognostic value of tumor-infiltrating lymphocytes in the anthracycline-based chemotherapy, Invitrogen CD3E antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 2). Breast Cancer Res (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to characterize two pathogenic, noncoding aberrations of UNC13D in patients with familial hemophagocytic lymphohistiocytosis, Invitrogen CD3E antibody (eBiosciences, UHCT1) was used in flow cytometry on human samples . Blood (2011) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2.5 ug/ml
Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 2.5 ug/ml. PLoS ONE (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...
  • immunohistochemistry; human
In order to study three clinical cases of follicular dendritic cell sarcoma, Invitrogen CD3E antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Hum Pathol (2012) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD3E antibody (eBioscience, 46-0037-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 5C
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD3E antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:150 (fig 5C). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 5
In order to assess the immune responses of peripheral blood to chlamydial antigens, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 5). Front Microbiol (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen CD3E antibody (Lab vision, RM-9107) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen CD3E antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s2
In order to track T cells after transplantation, Invitrogen CD3E antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig s2). EMBO Mol Med (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to describe methods to mimic peripheral lymphoid organs in vitro, Invitrogen CD3E antibody (Caltag, MHCD0318) was used in flow cytometry on human samples (fig 2). Biotechnol Bioeng (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the regulation of the CD4 and CD8 T cell pools during HIV infection, Invitrogen CD3E antibody (Invitrogen, clone UHCT1) was used in flow cytometry on human samples . J Immunol (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify immunological/virological biomarkers associated with sleep quality in patients with chronic hepatitis C, Invitrogen CD3E antibody (Caltag, MHCD0306) was used in flow cytometry on human samples (fig 1). Scand J Immunol (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 3
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD3E antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (tbl 3). Vaccine (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 3
  • immunohistochemistry; human
In order to investigate the localization of the prolactin receptor in atherosclerotic plaques, Invitrogen CD3E antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunohistochemistry on human samples . J Endocrinol (2011) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2
In order to investigate IL-15-driven NK receptor induction in CD8+ T cells, Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 2). Immunobiology (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study the molecular mechanisms that regulate the "recall" NK cell response after rabies vaccination, Invitrogen CD3E antibody (Caltag/Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study T regulatory cells in inflamed human liver samples, Invitrogen CD3E antibody (eBioscience, UCHT-1) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (7D6)
  • other; human; fig 2
In order to develop a procedure for the disaggregation of colorectal cancers and normal intestinal mucosal tissues to produce single cell suspensions and assess surface antigens, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in other on human samples (fig 2). J Immunol Methods (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify biomarkers in the first synovial fluid aspirate obtained from children with oligoarticular juvenile idiopathic arthritis, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Arthritis Rheum (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study IL-7 receptor expression and IL-7 signaling in human thymocytes, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). Hum Immunol (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to assess the safety and efficacy of bone marrow-derived mesenchymal stem cells in two systemic lupus erythematosus patients, Invitrogen CD3E antibody (Caltag, MHCD0304) was used in flow cytometry on human samples . Lupus (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 1:20; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD3E antibody (CalTag, clone MHCD0304) was used in flow cytometry on human samples at 1:20 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to study the improvement of simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry by quantum dots thermal stability, Invitrogen CD3E antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD3E antibody (Caltag/Invitrogen, S4.1) was used in flow cytometry on human samples . Nat Protoc (2008) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
In order to characterize lymphocyte subgroups in peripheral blood of advanced stage lung cancer patients, Invitrogen CD3E antibody (eBioscience, 15-0038) was used in flow cytometry on human samples (tbl 1). Med Oncol (2010) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 1
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen CD3E antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 1). PLoS ONE (2008) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; rhesus macaque; fig 4
  • flow cytometry; human; fig 4
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on rhesus macaque samples (fig 4) and in flow cytometry on human samples (fig 4). J Virol (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to correlate Notch receptor expression and the severity of systemic lupus erythematosus disease, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Lupus (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study the effect of EBV load in patients with rheumatoid arthritis, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2). J Immunol (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop a 6-color assay to identify dendritic cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 2a
In order to demonstrate that aerosolized interferon-gamma results in the transient conversion of sputum smears in multidrug-resistant pulmonary tuberculosis, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2a). Int J Tuberc Lung Dis (2008) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human
In order to determine the relationship between organophosphate pesticide exposure and biomarkers of oxidative stress and DNA damage, Invitrogen CD3E antibody (Invitrogen, S4.1) was used in blocking or activating experiments on human samples . Toxicol Appl Pharmacol (2008) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human; 0.1 ug/ml; fig 3c
In order to generate a selectable lentiviral vector with a proliferative advantage to study transgene immunogenicity in gene-modified T cells, Invitrogen CD3E antibody (Caltag/Invitrogen, S4.1) was used in blocking or activating experiments on human samples at 0.1 ug/ml (fig 3c). Gene Ther (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize human Th17 cells, Invitrogen CD3E antibody (CalTag, MHCD0306) was used in flow cytometry on human samples . Nat Immunol (2007) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to develop a system for the decoration of enveloped viruses with functionally active cytokines, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Virol (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to identify and characterize the receptor encoded by KIR2DL5, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia in chronic phase, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Leukemia (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study GATA-3 and T-box expression in human T cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Blood (2007) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.5 ug/ml
In order to measure T cell responses to a tumor-associated antigen and test if T regulatory cells affect those anti-tumor immune responses in patients with colorectal cancer, Invitrogen CD3E antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.5 ug/ml. PLoS ONE (2006) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 4
Invitrogen CD3E antibody (eBioscience, HIT3a) was used in flow cytometry on human samples (fig 4). J Virol (2006) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to assess the T cell-stimulatory capacity of mature dendritic cells and macrophages using a model of allogeneic MLR, Invitrogen CD3E antibody (eBioscience, OKT-3) was used in blocking or activating experiments on human samples . J Immunol (2006) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3E antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop methods to establish long-term, antigen-specific T-cell lines and clones, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Immunol Lett (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig s1
In order to test if delta-1 affects the formation of human plasmacytoid dendritic cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig s1). Blood (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to investigate the role of ORF66 kinase of varicella-zoster virus using T cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Virol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study how macrophages and serum factors contribute to the development of systemic lupus erythematosus, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Ann Rheum Dis (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize natural killer cells in the decidua of sporadic miscarriages and induced abortions, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Mol Hum Reprod (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD3E antibody (Caltag Laboratories, S4.1) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (SPV-T3b)
  • flow cytometry; human; fig 2
In order to elucidate how interleukin-4 promotes the development of T helper type 2 cells, Invitrogen CD3E antibody (Zymed, SPV-T3b) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD3E antibody (Caltag Laboratories, S4.1) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to elucidate how the monoclonal antibody, 11C9, reduces dendritic cell-induced T cell activation, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to investigate T cell-mediated transfer of varicella-zoster virus to skin, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Exp Med (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize human CD133+ HPCs, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Transfusion (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the life-cycle events of HIV-1 in primary cultures of human uterine epithelial cells and stromal fibroblasts, Invitrogen CD3E antibody (Caltag, MHCD0301) was used in flow cytometry on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 1
In order to characterize natural killer cells in women with recurrent spontaneous abortion of unexplained etiology, Invitrogen CD3E antibody (CALTAG, S4.1) was used in flow cytometry on human samples (tbl 1). Am J Reprod Immunol (2004) ncbi
mouse monoclonal (SPV-T3b)
  • blocking or activating experiments; human; 1 ug/ml
In order to investigate the role of LIR-2 in dendritic cells, Invitrogen CD3E antibody (Zymed, SPV-T3b) was used in blocking or activating experiments on human samples at 1 ug/ml. Eur J Immunol (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD3E antibody (Zymed, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • immunohistochemistry - frozen section; human; fig 1
In order to study the effect of leukemia inhibitor factor on HIV replication, Invitrogen CD3E antibody (Caltag Laboratories, clone S4.1) was used in immunohistochemistry - frozen section on human samples (fig 1). AIDS (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to examine adhesion molecules in patients with restenosis, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to assess the ability of a modified cell separator system to isolate monocytes by elutriation, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 2). Transfusion (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study the effect of lacking ICOS in patients with common variable immunodeficiency, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). Nat Immunol (2003) ncbi
mouse monoclonal (SPV-T3b)
  • immunohistochemistry - paraffin section; human; fig 4
In order to identify a timeframe in human and pig kidney organogenesis that may be optimal for transplantation, Invitrogen CD3E antibody (Zymed, 070303) was used in immunohistochemistry - paraffin section on human samples (fig 4). Nat Med (2003) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD3E antibody (Caltag, OKT3) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 4 ug/ml
In order to characterize human splenic dendritic cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples at 4 ug/ml. Blood (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to elucidate the mechanisms that promote recruitment and survival of T cells within the pediatric inflamed joint, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to assess cryptomonad-derived phycobiliproteins for their applicability to flow cytometry, Invitrogen CD3E antibody (Caltag Laboratories, clone S4.1) was used in flow cytometry on human samples (fig 3). Cytometry (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to compare the immune responses of T cells isolated from human secondary lymphoid organs and peripheral blood, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 4). Int Immunol (2001) ncbi
mouse monoclonal (SPV-T3b)
  • other; bovine
In order to study how extracellular matrix-embedded cytokines regulate thyroid cell surface molecules, Invitrogen CD3E antibody (Zymed, SPV-T3b) was used in other on bovine samples . Thyroid (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to discuss studying rhesus macaques infected with simian immunodeficiency viruses or simian-human immunodeficiency viruses, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to optimize B- and T-lymphoid lineage detection in acute leukemias by intracellular staining for myeloperoxidase, CD79a, and CD3, Invitrogen CD3E antibody (Caltag, clone S4.1) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify factors that down regulate CD4 on cultured monocytes, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Clin Diagn Lab Immunol (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 5
In order to discuss methods of CD34+ cell selection from blood, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 5). Transfusion (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD3E antibody (Caltag, S4-1) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse
In order to elucidate role of SOD-1 overexpression in thymocyte biology, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study selective expression of cytokines by T cells, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Immunol (1999) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to determine the functional properties of CK beta-11/MIP-3 beta/ELC, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 4). J Immunol (1998) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 5
In order to report an in vitro assay for thymic T-cell development, Invitrogen CD3E antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 5). Blood (1998) ncbi
mouse monoclonal (7D6)
  • immunocytochemistry; human; fig 3
In order to report that human hematopoietic cells survive and proliferate in severe combined immunodeficient mice treated with busulfan and cyclophosphamide, Invitrogen CD3E antibody (Caltag, S4.1) was used in immunocytochemistry on human samples (fig 3). Stem Cells (1997) ncbi
mouse monoclonal (7D6)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD3E antibody (Caltag, S4.1) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
mouse monoclonal (S4.1 (7D6))
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3E antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (7D6)
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3E antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (S4.1)
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3E antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to review TCR alpha/beta-T3 complex expression and formation, Invitrogen CD3E antibody (noco, UCHT1) was used in flow cytometry on human samples . Cell (1986) ncbi
mouse monoclonal (S4.1 (7D6))
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3E antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
mouse monoclonal (7D6)
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3E antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
mouse monoclonal (S4.1)
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3E antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
Abcam
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig s11
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig s11). Nat Commun (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Mol Cell Proteomics (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5a
Abcam CD3E antibody (Abcam, 5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5a). Biomedicines (2022) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 4e
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 4e). EBioMedicine (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1d
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1d) and in immunocytochemistry on human samples at 1:100 (fig 1c). Signal Transduct Target Ther (2022) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig s6d
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig s6d). Nat Commun (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 7b
Abcam CD3E antibody (Abcam, ab34275) was used in flow cytometry on human samples (fig 7b). Redox Biol (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig s6e
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig s6e). Theranostics (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s1c
Abcam CD3E antibody (Abcam, AB5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s1c). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 7e
Abcam CD3E antibody (Abcam, 5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 7e). Front Med (Lausanne) (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 7c
Abcam CD3E antibody (Abcam, 145-2C11) was used in flow cytometry on mouse samples (fig 7c). J Clin Invest (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Antioxidants (Basel) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6g
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6g). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:100; loading ...; fig 7e
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 7e). Front Cell Neurosci (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4c
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 4c). ESC Heart Fail (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2f
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2f). J Am Heart Assoc (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; 1:250; loading ...
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry on mouse samples at 1:250. Animals (Basel) (2020) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
Abcam CD3E antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a). J Clin Invest (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 4d
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry on mouse samples at 1:200 (fig 4d). elife (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on human samples . Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on human samples (fig 2d). Aging Cell (2020) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; rhesus macaque; 2 ug/ml; loading ...; fig s8b
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 2 ug/ml (fig s8b). Science (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Abcam CD3E antibody (Abcam, AB5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Cell (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4c
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4c). Transl Oncol (2020) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; rhesus macaque; 1:100; loading ...; fig 5i
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - frozen section on rhesus macaque samples at 1:100 (fig 5i). Mol Ther Methods Clin Dev (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s13f
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on mouse samples (fig s13f). Science (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; loading ...; fig s7d
Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on human samples (fig s7d). Cell (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; loading ...; fig e9a
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e3e
Abcam CD3E antibody (Abcam, CD3-12) was used in immunohistochemistry - paraffin section on human samples (fig e9a) and in immunohistochemistry - paraffin section on mouse samples (fig e3e). Nature (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). BMC Nephrol (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s6b
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig s6b). Science (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; loading ...; fig 2a, 3a
Abcam CD3E antibody (Abcam, CD3-C12) was used in immunohistochemistry on mouse samples (fig 2a, 3a). J Immunol (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3d
Abcam CD3E antibody (AbCam, ab11089) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3d). Pulm Circ (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Oncoimmunology (2018) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 2c
Abcam CD3E antibody (Abcam, 133628) was used in western blot on human samples (fig 2c). J Immunol (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; 1:200; loading ...; fig 7a
In order to develop and characterize a rat model of glioma, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on rat samples at 1:200 (fig 7a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 38
In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on mouse samples (fig 38). J Toxicol Pathol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 4d
In order to examine IFN responses by cerebellar astrocytes during viral infection, Abcam CD3E antibody (Abcam, ab16044) was used in immunohistochemistry on mouse samples (fig 4d). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s6b
In order to generate and characterize rat-sized pancreata composed of mouse-derived pluripotent stem cells, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig s6b). Nature (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 1j
In order to investigate the role of mitogen-activated protein kinase in pancreatitis, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on mouse samples (fig 1j). Cell Mol Gastroenterol Hepatol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 4c
In order to study the role of oxidative stress in optic neuritis, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 4c). Mol Vis (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5a
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4d
In order to study histone deacetylase 9 in diffuse large B-cell lymphoma, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 4d). Dis Model Mech (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 3
Abcam CD3E antibody (Abcam, ab16044) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). BMC Complement Altern Med (2016) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 8a
In order to use poly(ethylene glycol)-functionalized-hydrophilic carbon clusters to track T cells in vivo, Abcam CD3E antibody (Abcam, ab11089) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 8a). NMR Biomed (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:150; fig s6q
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - frozen section on mouse samples at 1:150 (fig s6q). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:75; loading ...; fig 3e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Abcam CD3E antibody (Abcam, Ab5690) was used in immunohistochemistry on mouse samples at 1:75 (fig 3e). Gut (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:50; fig 6
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 5
Abcam CD3E antibody (Abcam, Ab5690) was used in immunohistochemistry on mouse samples (fig 5). Nat Cell Biol (2016) ncbi
mouse monoclonal (PS1)
  • immunohistochemistry - frozen section; human; fig s4b
Abcam CD3E antibody (Abcam, ab699) was used in immunohistochemistry - frozen section on human samples (fig s4b). Arthritis Res Ther (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:250; loading ...; fig 5b
Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on mouse samples at 1:250 (fig 5b). Mol Vis (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3e
Abcam CD3E antibody (AbCam, ab5690) was used in immunohistochemistry on mouse samples at 1:200 (fig 3e). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
In order to research the role of C9orf72 in macrophage and microglial function, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Science (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Abcam CD3E antibody (abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig 7). elife (2016) ncbi
mouse monoclonal (PS1)
  • immunohistochemistry; human; fig 4
In order to measure TGF-beta1 expression in the gastrocnemius of control subjects and patients with peripheral artery disease and also assess collagen, fibroblast accumulation, and limb hemodynamics in these patients, Abcam CD3E antibody (Abcam, Ab699) was used in immunohistochemistry on human samples (fig 4). J Transl Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100
Abcam CD3E antibody (abcam, ab5690) was used in immunohistochemistry - frozen section on mouse samples at 1:100. J Transl Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig s1
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry on mouse samples at 1:100 (fig s1). Nat Neurosci (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s4
In order to determine stromal miR-143/145 microRNAs promote tumorigenesis, Abcam CD3E antibody (Abcam, ab5690) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). Cancer Discov (2016) ncbi
mouse monoclonal (PS1)
  • immunohistochemistry - paraffin section; human; 1:5; tbl 3
In order to determine the expression of thymic stromal lymphopoietin and its receptor in Kimura's disease, Abcam CD3E antibody (Abcam, PS1) was used in immunohistochemistry - paraffin section on human samples at 1:5 (tbl 3). ORL J Otorhinolaryngol Relat Spec (2015) ncbi
mouse monoclonal (PS1)
  • immunohistochemistry; human
Abcam CD3E antibody (Abcam, ab699) was used in immunohistochemistry on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (PS1)
  • immunohistochemistry - paraffin section; human; 1:50
Abcam CD3E antibody (Abcam, ab699) was used in immunohistochemistry - paraffin section on human samples at 1:50. Br J Dermatol (2014) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:100
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to study the potential involvement of transglutaminase-2 in bronchopulmonary dysplasia, Abcam CD3E antibody (Abcam, Ab424) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunohistochemistry - paraffin section on mouse samples at 1:100. Eur Respir J (2014) ncbi
Bio-Rad
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 2e
Bio-Rad CD3E antibody (Bio-Rad, MCA1477) was used in immunohistochemistry on mouse samples at 1:300 (fig 2e). EMBO Mol Med (2022) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:600; loading ...; fig 4c
Bio-Rad CD3E antibody (Bio-Rad, MCA1477T) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 4c). Sci Transl Med (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 1f
Bio-Rad CD3E antibody (Serotec, MCA 1477) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 1f). Int J Mol Sci (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; crab eating macaque; 1:600; loading ...; fig s5e
Bio-Rad CD3E antibody (BioRad, MCA1477) was used in immunohistochemistry on crab eating macaque samples at 1:600 (fig s5e). Cell (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; 1:150; loading ...; fig 4a
Bio-Rad CD3E antibody (Serotec, MCA1477) was used in immunohistochemistry on mouse samples at 1:150 (fig 4a). Brain Pathol (2021) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; loading ...; fig s1
Bio-Rad CD3E antibody (AbD Serotec, MCA1477) was used in immunohistochemistry on mouse samples (fig s1). Front Physiol (2020) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
Bio-Rad CD3E antibody (Sigma, MCA1477T) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). JACC Basic Transl Sci (2020) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 5b
Bio-Rad CD3E antibody (Bio-Rad, MCA1477) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5b). Nature (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e8d
Bio-Rad CD3E antibody (Bio-Rad, MCA1477T) was used in immunohistochemistry - paraffin section on mouse samples (fig e8d). Nature (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 1a
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 1a
Bio-Rad CD3E antibody (Biorad/Serotec, MCA1477) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1a) and in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1a). JCI Insight (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4b
Bio-Rad CD3E antibody (Bio-Rad, MCA1477) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4b). FASEB J (2019) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; loading ...; fig 1b
Bio-Rad CD3E antibody (AbD Serotec, MC1477) was used in immunohistochemistry on mouse samples (fig 1b). J Exp Med (2018) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; dogs; loading ...; fig 5
In order to evaluate the use of valspodar to treat canine B-cell lymphoma, Bio-Rad CD3E antibody (AbD serotec, MCA1477) was used in flow cytometry on dogs samples (fig 5). F1000Res (2015) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1c
Bio-Rad CD3E antibody (Serotec, MCA1477) was used in immunohistochemistry - paraffin section on mouse samples (fig 1c). Nat Commun (2017) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
Bio-Rad CD3E antibody (Bio-Rad, MCA1477T) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). Sci Rep (2016) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; mouse; 1:200; fig 2
Bio-Rad CD3E antibody (Serotec, MCA1477) was used in flow cytometry on mouse samples at 1:200 (fig 2). J Neuroinflammation (2016) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; mouse; fig 6e
Bio-Rad CD3E antibody (Serotec, MCA1477) was used in flow cytometry on mouse samples (fig 6e). J Neuroinflammation (2016) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; pigs ; 1:100; loading ...; fig 1
Bio-Rad CD3E antibody (Biorad, MCA1477) was used in immunohistochemistry - paraffin section on pigs samples at 1:100 (fig 1). PLoS Negl Trop Dis (2016) ncbi
rat monoclonal (CD3-12)
  • immunocytochemistry; human; fig 3
Bio-Rad CD3E antibody (AbDSerotec, 1477) was used in immunocytochemistry on human samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Bio-Rad CD3E antibody (Serotec, CD3-12) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Nat Immunol (2015) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse; 1:500; fig 4d
In order to determine the immune profile of a murine ovarian cancer model., Bio-Rad CD3E antibody (AbD Serotec, MCA1477) was used in immunohistochemistry on mouse samples at 1:500 (fig 4d). J Immunother Cancer (2015) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; human
Bio-Rad CD3E antibody (AbD Serotec, CD3-12) was used in immunohistochemistry on human samples . Histochem Cell Biol (2015) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; human; fig 7
Bio-Rad CD3E antibody (Serotec, MCA1711C) was used in flow cytometry on human samples (fig 7). PLoS ONE (2015) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; domestic rabbit; fig 8
Bio-Rad CD3E antibody (AbD Serotec, MCA1477) was used in flow cytometry on domestic rabbit samples (fig 8). PLoS ONE (2015) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; African green monkey
Bio-Rad CD3E antibody (AbD Serotec, CD3-12) was used in immunohistochemistry - paraffin section on African green monkey samples . Am J Transplant (2015) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry - frozen section; human; 1 ug/ml; fig 3a
Bio-Rad CD3E antibody (AbDSerotec, UCHT1) was used in immunohistochemistry - frozen section on human samples at 1 ug/ml (fig 3a). J Clin Invest (2015) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse; fig 2
Bio-Rad CD3E antibody (Serotic, CD3-12) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Am J Pathol (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:100
Bio-Rad CD3E antibody (Serotec, CD3-12) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Immunol (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; dogs; 1:500
Bio-Rad CD3E antibody (Serotec, MCA1477T) was used in immunohistochemistry on dogs samples at 1:500. PLoS ONE (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; human; 1:100
Bio-Rad CD3E antibody (AbD Serotec, MCA1477) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Neurol (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; dogs; 1:50
In order to compare two treatment regiments for idiopathic inflammatory bowel disease, Bio-Rad CD3E antibody (Serotec, MCA1477) was used in immunohistochemistry on dogs samples at 1:50. PLoS ONE (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry; mouse
Bio-Rad CD3E antibody (Serotec, MCA1477) was used in immunohistochemistry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - paraffin section; mouse
Bio-Rad CD3E antibody (AbD Serotec, CD3-12) was used in immunohistochemistry - paraffin section on mouse samples . Mucosal Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to discuss methods to detect fetomaternal hemorrhage, Bio-Rad CD3E antibody (Serotec, Clone UCHT1) was used in flow cytometry on human samples (fig 1). Transfusion (2014) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; mouse
Bio-Rad CD3E antibody (Serotec, CD3-12) was used in immunohistochemistry - frozen section on mouse samples . J Neuroinflammation (2013) ncbi
rat monoclonal (CD3-12)
  • immunocytochemistry; cat
Bio-Rad CD3E antibody (Serotec, CD3-12) was used in immunocytochemistry on cat samples . Can Vet J (2011) ncbi
Santa Cruz Biotechnology
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc-137096) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). J Cell Mol Med (2022) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc20047) was used in immunohistochemistry on mouse samples at 1:1000 (fig 5d). Nat Commun (2021) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2a
Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc-20047) was used in immunohistochemistry on mouse samples at 1:200 (fig 2a). Cell Death Dis (2021) ncbi
mouse monoclonal (A-1)
  • western blot; mouse; 1:1000; loading ...; fig 6c
Santa Cruz Biotechnology CD3E antibody (Santa, sc-137095) was used in western blot on mouse samples at 1:1000 (fig 6c). Nat Commun (2018) ncbi
mouse monoclonal (UCH-T1)
  • immunohistochemistry - frozen section; human; loading ...; fig 2d
Santa Cruz Biotechnology CD3E antibody (Santa Cruz, Sc-1179) was used in immunohistochemistry - frozen section on human samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; human; 1:200
Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc-20047) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncol Lett (2016) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s8a
Santa Cruz Biotechnology CD3E antibody (SantaCruz, sc-20047) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s8a). Nat Commun (2016) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5a
In order to study the T-cell depletion protective effect in the heart of diabetic Rag1 KO mice., Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc-20047) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a). Int Immunopharmacol (2016) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
Santa Cruz Biotechnology CD3E antibody (santa Cruz, sc-20047) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (PC3/188A)
  • flow cytometry; rat; 1:1000
Santa Cruz Biotechnology CD3E antibody (Santa Cruz Biotechnology, sc-20047) was used in flow cytometry on rat samples at 1:1000. Mol Med Rep (2015) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; mouse; fig 6
Santa Cruz Biotechnology CD3E antibody (Santa Cruz Biotechnology, SC-20047) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). J Biol Chem (2015) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to test if inhibition of PKC-theta protect diabetic hearts by suppressing T-cell stimulation and maintaining tight junction integrity, Santa Cruz Biotechnology CD3E antibody (Santa, sc20047) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Br J Pharmacol (2014) ncbi
mouse monoclonal (PC3/188A)
  • immunohistochemistry; mouse
In order to investigate the role of hepatocyte growth factor receptor, c-met in renoprotection, Santa Cruz Biotechnology CD3E antibody (Santa Cruz, sc-20047) was used in immunohistochemistry on mouse samples . Kidney Int (2013) ncbi
Miltenyi Biotec
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 2b
Miltenyi Biotec CD3E antibody (Miltenyi Biotec, 130-093-387) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 2b). PLoS ONE (2022) ncbi
human monoclonal (REA613)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD3E antibody (Miltenyi, 130-113-138) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
human monoclonal (REA613)
  • flow cytometry; mouse; loading ...; fig s2a
Miltenyi Biotec CD3E antibody (Miltenyi Biotec, 130-113-141) was used in flow cytometry on mouse samples (fig s2a). Cell (2020) ncbi
human monoclonal (REA613)
  • flow cytometry; human; loading ...; fig 1a
Miltenyi Biotec CD3E antibody (Miltenyi Biotec, REA613) was used in flow cytometry on human samples (fig 1a). JCI Insight (2017) ncbi
Novus Biologicals
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; loading ...; fig 4d
Novus Biologicals CD3E antibody (Novus, SP7) was used in immunohistochemistry on human samples at 1:100 (fig 4d). Acta Neuropathol (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
  • immunohistochemistry - paraffin section; human; loading ...; fig s5
Novus Biologicals CD3E antibody (Novus, NB600-1441) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c) and in immunohistochemistry - paraffin section on human samples (fig s5). Oncogene (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 1e
Novus Biologicals CD3E antibody (Novus Biological, SP7) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 1e). Nature (2019) ncbi
Bio X Cell
mouse monoclonal (UCHT1 (Leu-4)(T3))
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, Bio X Cell CD3E antibody (BioXCell, UCHT1) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (OKT-3)
  • blocking or activating experiments; human; loading ...; fig 3
In order to assess the role of glycogen synthase kinase-3 in the production of IL-10 by CD4 positive T helper cells, Bio X Cell CD3E antibody (BioXCell, OKT3) was used in blocking or activating experiments on human samples (fig 3). Eur J Immunol (2015) ncbi
Boster
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 4a
Boster CD3E antibody (Boster, PB9093) was used in immunohistochemistry on mouse samples at 1:200 (fig 4a). Front Immunol (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4V8L)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5d
Cell Signaling Technology CD3E antibody (Cell Signaling, 99940) was used in immunohistochemistry - paraffin section on mouse samples (fig 5d). Aging (Albany NY) (2022) ncbi
domestic rabbit monoclonal (D4V8L)
  • immunohistochemistry; mouse; loading ...; fig s7a
Cell Signaling Technology CD3E antibody (Cell Signaling, 99940) was used in immunohistochemistry on mouse samples (fig s7a). iScience (2022) ncbi
domestic rabbit monoclonal (D4V8L)
  • immunohistochemistry; mouse; 1:200; fig 2c, 2f
Cell Signaling Technology CD3E antibody (Cell Signaling, 99940) was used in immunohistochemistry on mouse samples at 1:200 (fig 2c, 2f). J Immunother Cancer (2021) ncbi
domestic rabbit monoclonal (D4V8L)
  • immunohistochemistry; mouse; loading ...; fig s4a
Cell Signaling Technology CD3E antibody (Cell Signaling, 99940) was used in immunohistochemistry on mouse samples (fig s4a). Cells (2021) ncbi
domestic rabbit monoclonal (D4V8L)
  • immunohistochemistry; mouse; fig 3e
Cell Signaling Technology CD3E antibody (Cell Signaling Technology, D4V8L) was used in immunohistochemistry on mouse samples (fig 3e). Nat Commun (2020) ncbi
rat monoclonal (CD3-12)
  • flow cytometry; human; 1:1000; loading ...; tbl 1
Cell Signaling Technology CD3E antibody (Cell signaling, 4443) was used in flow cytometry on human samples at 1:1000 (tbl 1). Exp Ther Med (2016) ncbi
Exbio
mouse monoclonal (MEM-57)
  • flow cytometry; human; fig 2
Exbio CD3E antibody (Exbio, A7-202-T100) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2015) ncbi
Fitzgerald Industries
  • immunocytochemistry; human; 1:250
  • western blot; human; 1:500; fig 2
Fitzgerald Industries CD3E antibody (Fitzgerald, 10C-CR8008M1) was used in immunocytochemistry on human samples at 1:250 and in western blot on human samples at 1:500 (fig 2). Int J Oncol (2014) ncbi
National Institutes of Health AIDS Research and Reference Reagent Program
unidentified recombinant (12277)
  • flow cytometry; human; loading ...; fig s1a
National Institutes of Health AIDS Research and Reference Reagent Program CD3E antibody (NHP Reagents, PR-3802) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
Tonbo Biosciences
monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
Tonbo Biosciences CD3E antibody (Tonbo Biosciences, OKT3) was used in flow cytometry on human samples (fig 1a). Oncotarget (2017) ncbi
BD Biosciences
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 2d). Med Oncol (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 8a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 8a). J Clin Invest (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s7
BD Biosciences CD3E antibody (BD Pharmingen, 555332) was used in flow cytometry on human samples (fig s7). Oncoimmunology (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:300; loading ...; fig 6a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples at 1:300 (fig 6a). Nat Commun (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3c, 3d
BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples (fig 3c, 3d). J Immunother Cancer (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BD Biosciences CD3E antibody (BD Biosciences, 555341) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 2a). Int J Mol Sci (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 1b). Acta Neuropathol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:500; loading ...
BD Biosciences CD3E antibody (BD, 555332) was used in flow cytometry on human samples at 1:500. Cell (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:200; loading ...; fig s1h
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples at 1:200 (fig s1h). Nature (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 4
BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples (fig 4). Aging Cell (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:50; loading ...; fig 3s2a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples at 1:50 (fig 3s2a). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 3a). BMC Cancer (2020) ncbi
mouse monoclonal (UCHT1)
  • other; mouse
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD3E antibody (BD Biosciences, 552851/339186) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 1f
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 1f). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (BD, UCHT-1) was used in flow cytometry on human samples (fig 1a). Rheumatology (Oxford) (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 2a). J Extracell Vesicles (2020) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 1d
BD Biosciences CD3E antibody (BD Biosciences, 550368) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 1d). elife (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig s1a). Sci Adv (2020) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; loading ...; fig s2a
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on mouse samples (fig s2a) and in flow cytometry on human samples (fig s2a). Nature (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD3E antibody (BD Bioscience, 560365) was used in flow cytometry on human samples (fig 5c). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD, 347347) was used in flow cytometry on human samples (fig 1). J Cancer (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig s3a). Science (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:50; fig 4c
BD Biosciences CD3E antibody (BD, 557851) was used in flow cytometry on human samples at 1:50 (fig 4c). Nature (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 3d). Nature (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
BD Biosciences CD3E antibody (BD Pharmagen, 340440) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:1000; loading ...; fig 4d
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples at 1:1000 (fig 4d). PLoS Pathog (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 3
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 3). Sci Rep (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:20; loading ...; fig 5k, s22c
BD Biosciences CD3E antibody (BD Biosciences, 561416) was used in flow cytometry on human samples at 1:20 (fig 5k, s22c). Nat Commun (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s1). JCI Insight (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:200; loading ...; fig 2s1b
BD Biosciences CD3E antibody (BD, 555339) was used in flow cytometry on human samples at 1:200 (fig 2s1b). elife (2019) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s3a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s3a). J Invest Dermatol (2019) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...; fig s1
BD Biosciences CD3E antibody (BD, UCHT1) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 1-10 ug/ml; loading ...; fig s2g
BD Biosciences CD3E antibody (BD, 555336) was used in blocking or activating experiments on human samples at 1-10 ug/ml (fig s2g). J Exp Med (2019) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry - frozen section; human; loading ...; fig 1b
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in immunohistochemistry - frozen section on human samples (fig 1b). J Clin Invest (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s1a). Eur J Immunol (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 1a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 4a). J Immunol (2019) ncbi
mouse monoclonal (HIT3a)
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used . Am J Transplant (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s5b, s5c
BD Biosciences CD3E antibody (BD, 339186) was used in flow cytometry on human samples (fig s5b, s5c). Cell (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s3). J Infect Dis (2019) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry; human; 1:100; fig 3a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in immunohistochemistry on human samples at 1:100 (fig 3a). Ann Allergy Asthma Immunol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1c). Int J Hematol (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s7c
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s7c). Leukemia (2019) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 5 ug/ml; loading ...; fig 1b
BD Biosciences CD3E antibody (BD Pharmingen, HIT3a) was used in flow cytometry on human samples at 5 ug/ml (fig 1b). J Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (BD Pharmingen, UCHT1) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s7b
BD Biosciences CD3E antibody (BD, 555916) was used in flow cytometry on human samples (fig s7b). Eur J Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6h, 6i
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 6h, 6i). Cancer Res (2018) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry - frozen section; human; loading ...; fig 2a
  • flow cytometry; human; fig 1b
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in immunohistochemistry - frozen section on human samples (fig 2a) and in flow cytometry on human samples (fig 1b). J Exp Med (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Biosciences, 557851) was used in flow cytometry on human samples (fig 2a). J Virol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD3E antibody (BD Biosciences, 555916) was used in flow cytometry on human samples (fig 1). Oncotarget (2018) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; loading ...; fig s13
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on mouse samples (fig s13). J Clin Invest (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 14
BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples (fig 14). Front Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences CD3E antibody (BD, 555332) was used in flow cytometry on human samples (fig 1e). J Exp Med (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3e
BD Biosciences CD3E antibody (BD Biosciences, 561806) was used in flow cytometry on human samples (fig 3e). Cell (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 4a). J Immunol (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 5a). Obes Facts (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 2b). Nat Med (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1a
BD Biosciences CD3E antibody (BD Biosciences, UCHT - 1) was used in flow cytometry on human samples (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s2
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s2e
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig s2e). Nature (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to evaluate the role of IL-32alpha in NK cell inhibition, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s8e
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig s8e). Nature (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 3a
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BD Biosciences CD3E antibody (BD Pharmingen, HIT3a) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (BD, HIT3a) was used in flow cytometry on human samples (fig 1a). J Exp Med (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BD Biosciences CD3E antibody (BD, HIT3a) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD3E antibody (BD Pharmingen, UCHT1) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s6d
In order to determine the role of PD-1 in regulating anti-tumor T cell reactivities, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s6d). Science (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5a
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 5a). Cancer Res (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6b
BD Biosciences CD3E antibody (BD Biosciences, 561807) was used in flow cytometry on human samples (fig 6b). Mol Ther Methods Clin Dev (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BD Biosciences CD3E antibody (BD, UCHT-1) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s2). Nature (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . J Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; loading ...; fig 2e
In order to show that the inducible nuclear dual-specificity MAP kinase phosphatase DUSP2 binds ERK3 and ERK4, BD Biosciences CD3E antibody (BD, 555329) was used in blocking or activating experiments on human samples (fig 2e). Sci Rep (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig S1a
BD Biosciences CD3E antibody (BD, 561807) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CD3E antibody (BD, HIT3a) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 5). Genome Med (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
BD Biosciences CD3E antibody (Pharmingen, SK7) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (fig s1). Haematologica (2017) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; loading ...; fig 2d
In order to assess the functional role of IL-31 in basophil biology, BD Biosciences CD3E antibody (BD Bioscience, HIT3a) was used in blocking or activating experiments on human samples (fig 2d). Clin Exp Allergy (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1). J Immunol Res (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1c
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s1c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig s12c
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples (fig s12c). J Clin Invest (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to screen to find antibodies that block HIV-1 acquisition and replication, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Virol (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 1c
In order to assess the frequencies of liver-infiltrating antibody-secreting B cells in primary biliary cholangitis and primary sclerosing cholangitis, BD Biosciences CD3E antibody (BD Pharmingen, HIT3a) was used in flow cytometry on human samples (fig 1c). J Autoimmun (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:20; loading ...; fig 1c
BD Biosciences CD3E antibody (BD Biosciences, 555332) was used in flow cytometry on human samples at 1:20 (fig 1c). Nat Commun (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5b
In order to investigate the role of natural killer cells to lymphangioleiomyomatosis pathogenesis, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 5b). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6
In order to evaluate the predictive values of the protective T-cell response for human cytomegalovirus disease, BD Biosciences CD3E antibody (BD Biosciences, UCHTI) was used in flow cytometry on human samples (fig 6). New Microbiol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a, 1e
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD3E antibody (BD Biosciences, 557851) was used in flow cytometry on human samples (fig 1a, 1e). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5a
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 5a). J Exp Med (2016) ncbi
mouse monoclonal (HIT3a)
  • immunohistochemistry - frozen section; human; fig 7b
In order to investigate the basis for T regulatory cell accumulation in melanoma, BD Biosciences CD3E antibody (BD Biosciences, HIT3A) was used in immunohistochemistry - frozen section on human samples (fig 7b). Cancer Res (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3c
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, BD Biosciences CD3E antibody (BD Biosciences, 557832) was used in flow cytometry on human samples (fig 3c). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry; human; loading ...; fig 2a
In order to assess the expression of prolactin by synovial macrophages and determine if prolactin alters macrophage activation, BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in immunohistochemistry on human samples (fig 2a). Rheumatology (Oxford) (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1a
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s1a). Sci Rep (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s1a). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig s2b
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig s2b). Oncotarget (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2e
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 2e). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1a). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1e
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 1e). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 3a
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD3E antibody (BD Pharmingen, HIT3a) was used in flow cytometry on human samples (fig 3a). Clin Cancer Res (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 4a
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1d
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1d). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples (fig s2). J Clin Invest (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig s3a). J Clin Invest (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3b
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 3b) and in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s3
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s3). Sci Rep (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5e
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 5e). J Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s5b
In order to investigate NF-KB signaling in natural killer cells, BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (fig s5b). Nat Commun (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:50; fig 1d
In order to develop and characterize a humanized ossicle xenotransplantation approach, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples at 1:50 (fig 1d). Nat Med (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3d
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 3d). J Leukoc Biol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:50; loading ...; fig 1e
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BD Biosciences CD3E antibody (BD, 557851) was used in flow cytometry on human samples at 1:50 (fig 1e). Nat Cell Biol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:100; fig 1
In order to elucidate the marked reduction of Nkp44/Nkp46-double positive natural killer cells by celiac disease-related inflammation, BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 5
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:40; fig 3
BD Biosciences CD3E antibody (BD PharMingen, 560365) was used in flow cytometry on human samples at 1:40 (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:50; fig 2
BD Biosciences CD3E antibody (BD PharMingen, 347347) was used in flow cytometry on human samples at 1:50 (fig 2). Oncoimmunology (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig s2). Eur J Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; fig 4
BD Biosciences CD3E antibody (BD Pharmigen, 555336) was used in blocking or activating experiments on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4
In order to report the results of the rituximab by intravenous and Intrathecai injection versus placebo in patients with low-inflammatory secondary progressive multiple sclerosis study, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 4). Ann Clin Transl Neurol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
In order to compare the immune compartmentalization between ileum and colon in healthy and inflamed mucosa, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1a). J Crohns Colitis (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
In order to determine mucosal characteristics of lymphocytic and collagenous colitis, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1). J Crohns Colitis (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to generate adenoviral vaccines that express HPV-16 E6 and E7 epitopes alone or fused with p16 and assess immune responses, BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in blocking or activating experiments on human samples at 1 ug/ml. J Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 5
BD Biosciences CD3E antibody (BD Bioscience, HIT3a) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 2b
In order to Targeting CD8(+) T cells prevents psoriasis development, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 2b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD3E antibody (BD Biosciences, 340661) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (fig 1b). J Virol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
In order to perform an antigenic analysis of Bla g 2 using antibodies, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . J Biol Chem (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 2e
In order to elucidate the role of TfR1 in adaptive immunity, BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples (fig 2e). Nat Genet (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study the use of bispecific T cell engager, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; mouse; fig 1c
BD Biosciences CD3E antibody (BD Biosciences, 555329) was used in blocking or activating experiments on mouse samples (fig 1c). Nat Commun (2015) ncbi
mouse monoclonal (HIT3a)
  • western blot; human; 2.5 ug/ml; fig 1
In order to study redox imbalance and how oxidative stress contributes to impaired GLUT3 modulation in Huntington's disease, BD Biosciences CD3E antibody (BD Biosciences, 555336) was used in western blot on human samples at 2.5 ug/ml (fig 1). Free Radic Biol Med (2015) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 2.5 ug/ml; fig 1
  • western blot; human; 2.5 ug/ml; fig 1
In order to assess JNK-dependent alternative splicing in T-cell activation through CELF2-mediated regulation of MKK7, BD Biosciences CD3E antibody (BD Biosciences, 555336) was used in blocking or activating experiments on human samples at 2.5 ug/ml (fig 1) and in western blot on human samples at 2.5 ug/ml (fig 1). Genes Dev (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig s4
BD Biosciences CD3E antibody (BD Biosciences, 555338) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD3E antibody (BD PharMingen, SK7) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 1a
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples (fig 1a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, 555332) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to report that alefacept depletes both memory T cells and NK cells, BD Biosciences CD3E antibody (Becton Dickinson, UCHT1) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 4
In order to characterize gut-associated gammadelta T-cells in HIV-infected individuals, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry; human; tbl s4
In order to study the involvement of COX/mPGES-1/PGE2 pathway in tumor inflammatory environment, BD Biosciences CD3E antibody (BD Biosciences, 347340) was used in immunohistochemistry on human samples (tbl s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; rhesus macaque
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on rhesus macaque samples . Vaccine (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD Bioscience, 557832) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 2a). Ann Rheum Dis (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, 560366) was used in flow cytometry on human samples . J Exp Med (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 4). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human
BD Biosciences CD3E antibody (BD Pharmingen, 555329) was used in blocking or activating experiments on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 2
BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (fig 2). Nat Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig S1
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CD3E antibody (BD Pharmingen, UCHT1) was used in flow cytometry on human samples (fig S1). Retrovirology (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HIT3a)
  • other; human; fig 2
In order to characterize capabilities and potentials of extracellular vesicle (EV) array, BD Biosciences CD3E antibody (BD Biosciences, 555337) was used in other on human samples (fig 2). J Extracell Vesicles (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (tbl 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 2:100; fig 3a
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in flow cytometry on human samples at 2:100 (fig 3a). Nat Commun (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1e
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples (fig 1e). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 5 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples at 5 ul/test. J Immunol Methods (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
  • flow cytometry; crab eating macaque
BD Biosciences CD3E antibody (BD, 340440) was used in flow cytometry on human samples and in flow cytometry on crab eating macaque samples . MAbs (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to discuss the role of CD47 modulation in treatment of chronic lymphocytic leukemia, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . PLoS Med (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BD Biosciences CD3E antibody (BD Biosciences, 555338) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
In order to study the human breast for transcriptional and epigenetic determinants, BD Biosciences CD3E antibody (BD Biosciences, 555338) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 2
BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples (tbl 2). Clin Transplant (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 2
BD Biosciences CD3E antibody (BD Pharmingen, SK7) was used in flow cytometry on human samples (fig 2). J Virol (2015) ncbi
mouse monoclonal (SK7)
  • blocking or activating experiments; human; fig s3
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in blocking or activating experiments on human samples (fig s3). Diabetes (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (Becton Dickinson, UCHT1) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences CD3E antibody (BD Pharmingen, clone SK7) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
In order to discover regulatory networks from epigenomes of surface ectoderm-derived cell types, BD Biosciences CD3E antibody (BD Biosciences, 555338) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2015) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 1 ug/ml
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences CD3E antibody (BD, Hit3a) was used in blocking or activating experiments on human samples at 1 ug/ml. Nat Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences CD3E antibody (BD, UCHT1) was used in blocking or activating experiments on human samples at 1 ug/ml. Nat Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; fig 2
BD Biosciences CD3E antibody (BD Pharmingen, 555329) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 2). Mol Cell Biol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; fig s3
BD Biosciences CD3E antibody (Pharmingen, 555332) was used in flow cytometry on mouse samples (fig s3). Stem Cell Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Pharmingen, UCHT1) was used in flow cytometry on human samples . J Hepatol (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples and in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, SK7) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to perform longitudinal and cross-sectional studies of patients after restorative proctocolectomy and assess tight junction proteins and dendritic cell characteristics in the ileal pouch, BD Biosciences CD3E antibody (BD Pharmingen, UCHT1) was used in flow cytometry on human samples . Inflamm Bowel Dis (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences CD3E antibody (BD Biosciences, Clone SK7) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (UCHT1)
  • immunocytochemistry; mouse
BD Biosciences CD3E antibody (PharMingen, UCHT1) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . Immunobiology (2015) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 1 ug/ml
In order to study the effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells and T-lymphocytes, BD Biosciences CD3E antibody (BD, 550367) was used in blocking or activating experiments on human samples at 1 ug/ml. Atherosclerosis (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Horizon, UCHT1) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 1 ug/ml
BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in blocking or activating experiments on human samples at 1 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; 1:100
BD Biosciences CD3E antibody (BD Biosciences, 555339) was used in flow cytometry on human samples at 1:100. J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:20
BD Biosciences CD3E antibody (BD Biosciences, 560365) was used in flow cytometry on human samples at 1:20. J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:40
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples at 1:40. Nat Commun (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (Becton Dickinson, UCHT1) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1.6:100
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples at 1.6:100. J Clin Invest (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry; human
BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in immunohistochemistry on human samples . Arthritis Rheumatol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; African green monkey; loading ...; fig 1a
In order to examine the role of IL-15 in HIV-infected chimpanzees, BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on African green monkey samples (fig 1a). Cell Immunol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; rat
In order to determine the effect of aging and CMV infection on T cell populations, BD Biosciences CD3E antibody (BD, 557832) was used in flow cytometry on rat samples . J Immunol (2014) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 10 ug/ml
In order to show that CKIP-1 interacts with CARMA1 and inhibits PKCtheta-CBM-NF-kappaB signaling, BD Biosciences CD3E antibody (BD, 555336) was used in blocking or activating experiments on human samples at 10 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
In order to examine the changes in erythrocytes and T-lymphocytes and to explore the mechanisms involved in stress-induced depression using a rat depression model, BD Biosciences CD3E antibody (BD Bio-sciences, clone SK7) was used in flow cytometry on human samples (tbl 1). Environ Toxicol Pharmacol (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD3E antibody (Becton Dickinson, SK7) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BD Biosciences CD3E antibody (BD, 555332) was used in flow cytometry on human samples . Nat Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD/Pharmingen, UCHT1) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, SK7) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD3E antibody (BD Bioscience, UCHT1) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD3E antibody (BD Bioscience, SK7) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD3E antibody (BD, clone SK7) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD Biosciences, UCHT1) was used in flow cytometry on human samples . Retrovirology (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BD Biosciences CD3E antibody (BD, UCHT1) was used in flow cytometry on human samples . Ann Rheum Dis (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1
BD Biosciences CD3E antibody (BD, 641406) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
BD Biosciences CD3E antibody (BD Pharmingen, 555332) was used in flow cytometry on human samples (fig 5). Cell Transplant (2014) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry - frozen section; human; 0.25 ug/ml
BD Biosciences CD3E antibody (BD Pharmingen, 555330) was used in immunohistochemistry - frozen section on human samples at 0.25 ug/ml. Neuropathol Appl Neurobiol (2014) ncbi
mouse monoclonal (SK7)
  • immunohistochemistry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, BD Biosciences CD3E antibody (BD, SK7) was used in immunohistochemistry on human samples . Blood (2008) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; mouse; fig 3
In order to determine the expression of CD39 in mouse and human T cells, BD Biosciences CD3E antibody (BD Biosciences, HIT3a) was used in flow cytometry on mouse samples (fig 3). Blood (2007) ncbi
MilliporeSigma
domestic rabbit monoclonal (SP162)
  • immunohistochemistry - paraffin section; rhesus macaque; loading ...; fig 7a
MilliporeSigma CD3E antibody (Sigma, SAB5500057) was used in immunohistochemistry - paraffin section on rhesus macaque samples (fig 7a). Cell (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; dogs; loading ...; fig 42
In order to outline the protocols for antibodies used for immunohistochemical studies, MilliporeSigma CD3E antibody (Sigma-aldrich, C7930) was used in immunohistochemistry on dogs samples (fig 42). J Toxicol Pathol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5a
In order to develop a novel mouse model to test the mechanisms mediating transformation of chronic inflammation into fibrosis, MilliporeSigma CD3E antibody (Sigma, C7930) was used in immunohistochemistry - paraffin section on mouse samples (fig s5a). PLoS ONE (2016) ncbi
Leica Biosystems
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:60; fig 2c
Leica Biosystems CD3E antibody (Novocastra, CD3-PS1) was used in immunohistochemistry - paraffin section on human samples at 1:60 (fig 2c). Mod Pathol (2015) ncbi
ATCC
mouse monoclonal
  • flow cytometry; human; 1 ug/ml; fig 1
ATCC CD3E antibody (ATCC, CRL-8001) was used in flow cytometry on human samples at 1 ug/ml (fig 1). Oncoimmunology (2016) ncbi
Nanotools
mouse monoclonal (4D7)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Nanotools CD3E antibody (Nanotools, 0172-100) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
Articles Reviewed
  1. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  2. Kaminski M, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, et al. TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. J Immunother Cancer. 2022;10: pubmed publisher
  3. Zhang T, Xia W, Song X, Mao Q, Huang X, Chen B, et al. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. J Hematol Oncol. 2022;15:114 pubmed publisher
  4. Coy S, Wang S, Stopka S, Lin J, Yapp C, Ritch C, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814 pubmed publisher
  5. Selle J, Dinger K, Jentgen V, Zanetti D, Will J, Georgomanolis T, et al. Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life. Nat Commun. 2022;13:4352 pubmed publisher
  6. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed publisher
  7. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed publisher
  8. Paldor M, Levkovitch Siany O, Eidelshtein D, Adar R, Enk C, Marmary Y, et al. Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis. EMBO Mol Med. 2022;14:e15653 pubmed publisher
  9. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  10. Rosa T, Mendes M, Linhares N, Rodrigues T, Dias A, Leal Calvo T, et al. The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. Front Med (Lausanne). 2022;9:899998 pubmed publisher
  11. Wang H, Chen L, Qi L, Jiang N, Zhang Z, Guo H, et al. A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma. Mol Cell Proteomics. 2022;21:100258 pubmed publisher
  12. Tosti E, Almeida A, Tran T, Barbachan E Silva M, Broin P, Dubin R, et al. Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer. Cell Mol Gastroenterol Hepatol. 2022;14:693-717 pubmed publisher
  13. Deal B, Reynolds L, PATTERSON C, Janjic J, Pollock J. Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation. Sci Rep. 2022;12:8472 pubmed publisher
  14. Andre A, Zhang L, Nix J, Elmadbouly N, Lucas A, Wilson Rawls J, et al. Myxomavirus Serp-1 Protein Ameliorates Inflammation in a Mouse Model of Duchenne Muscular Dystrophy. Biomedicines. 2022;10: pubmed publisher
  15. Qin L, Wang L, Zhang J, Zhou H, Yang Z, Wang Y, et al. Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer. Sci Adv. 2022;8:eabn3774 pubmed publisher
  16. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  17. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  18. Hickman T, Choi E, Whiteman K, Muralidharan S, Pai T, Johnson T, et al. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS ONE. 2022;17:e0266980 pubmed publisher
  19. Li H, Liu Z, Liu L, Zhang H, Han C, Girard L, et al. AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells. Cell Rep Med. 2022;3:100554 pubmed publisher
  20. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  21. Omari S, Geraghty D, Khalafallah A, Venkat P, Shegog Y, Ragg S, et al. Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Med Oncol. 2022;39:81 pubmed publisher
  22. Pascal L, Igarashi T, Mizoguchi S, Chen W, Rigatti L, Madigan C, et al. E-cadherin deficiency promotes prostate macrophage inflammation and bladder overactivity in aged male mice. Aging (Albany NY). 2022;14:2945-2965 pubmed publisher
  23. Wu X, Xia T, Shin W, Yu K, Jung W, Herrmann A, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13:e0040222 pubmed publisher
  24. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  25. R xfc tsche D, Michalak Mićka K, Zielinska D, Moll H, Moehrlen U, Biedermann T, et al. The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation. Cells. 2022;11: pubmed publisher
  26. Yang J, Zhang Q, Wang J, Lou Y, Hong Z, Wei S, et al. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. EBioMedicine. 2022;78:103958 pubmed publisher
  27. Cha J, Chan L, Wang Y, Chu Y, Wang C, Lee H, et al. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. J Biol Chem. 2022;298:101817 pubmed publisher
  28. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  29. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed publisher
  30. Maderna C, Pisati F, Tripodo C, Dejana E, Malinverno M. A murine model of cerebral cavernous malformations with acute hemorrhage. iScience. 2022;25:103943 pubmed publisher
  31. Meschkat M, Steyer A, Weil M, Kusch K, Jahn O, Piepkorn L, et al. White matter integrity in mice requires continuous myelin synthesis at the inner tongue. Nat Commun. 2022;13:1163 pubmed publisher
  32. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed publisher
  33. Dang G, Li T, Yang D, Yang G, Du X, Yang J, et al. T lymphocyte-derived extracellular vesicles aggravate abdominal aortic aneurysm by promoting macrophage lipid peroxidation and migration via pyruvate kinase muscle isozyme 2. Redox Biol. 2022;50:102257 pubmed publisher
  34. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  35. Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, et al. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer. 2022;10: pubmed publisher
  36. Pulkka O, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, et al. Fibrinogen-like protein 2 in gastrointestinal stromal tumour. J Cell Mol Med. 2022;26:1083-1094 pubmed publisher
  37. Du Y, Peng Q, Cheng D, Pan T, Sun W, Wang H, et al. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun. 2022;13:231 pubmed publisher
  38. Zhang Q, Hresko M, Picton L, Su L, Hollander M, Nunez Cruz S, et al. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13:eabg6986 pubmed publisher
  39. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  40. Ni Y, Hu B, Wu G, Shao Z, Zheng Y, Zhang R, et al. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11:9431-9451 pubmed publisher
  41. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed publisher
  42. Ming S, Yin H, Li X, Gong S, Zhang G, Wu Y. GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis. Front Immunol. 2021;12:736269 pubmed publisher
  43. Wright J, Bazile C, Clark E, Carlesso G, Boucher J, Kleiman E, et al. Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk. Front Immunol. 2021;12:705307 pubmed publisher
  44. Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C, et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22: pubmed publisher
  45. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  46. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  47. Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021;12:4821 pubmed publisher
  48. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  49. Guo D, Yamamoto M, Hernandez C, Khodadadi H, Baban B, Stranahan A. Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice. Nat Commun. 2021;12:4623 pubmed publisher
  50. Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher
  51. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  52. Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, et al. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci Rep. 2021;11:15075 pubmed publisher
  53. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  54. Goyette M, Elkholi I, Apcher C, Kuasne H, Rothlin C, Muller W, et al. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  55. Nathan A, Rossin E, Kaseke C, Park R, Khatri A, Koundakjian D, et al. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell. 2021;: pubmed publisher
  56. Hajihosseini A, Hutcherson C. Alpha oscillations and event-related potentials reflect distinct dynamics of attribute construction and evidence accumulation in dietary decision making. elife. 2021;10: pubmed publisher
  57. Niu G, Cui Y, Wang X, Keleta Y, Li J. Studies of the Parasite-Midgut Interaction Reveal Plasmodium Proteins Important for Malaria Transmission to Mosquitoes. Front Cell Infect Microbiol. 2021;11:654216 pubmed publisher
  58. Kwon D. This 'super antibody' for COVID fights off multiple coronaviruses. Nature. 2021;: pubmed publisher
  59. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  60. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  61. Maier J, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, et al. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  62. Altvater B, Kailayangiri S, Pérez Lanuza L, Urban K, Greune L, Flügge M, et al. HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells. Cancers (Basel). 2021;13: pubmed publisher
  63. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  64. Amanat F, Thapa M, Lei T, Ahmed S, Adelsberg D, Carreño J, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021;184:3936-3948.e10 pubmed publisher
  65. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  66. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  67. Al Ani M, Elemam N, Hachim I, Raju T, Muhammad J, Hachim M, et al. Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment. J Inflamm Res. 2021;14:2601-2617 pubmed publisher
  68. He X, Chandrashekar A, Zahn R, Wegmann F, Yu J, Mercado N, et al. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021;184:3467-3473.e11 pubmed publisher
  69. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed publisher
  70. Liu C, Chi K, Geng X, Hong Q, Mao Z, Huang Q, et al. Exogenous Biological Renal Support Improves Kidney Function in Mice With Rhabdomyolysis-Induced Acute Kidney Injury. Front Med (Lausanne). 2021;8:655787 pubmed publisher
  71. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  72. Zheng J, MEYERHOLZ D, Wong L, Gelb M, Murakami M, Perlman S. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D. J Clin Invest. 2021;131: pubmed publisher
  73. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed publisher
  74. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  75. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  76. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed publisher
  77. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  78. Egedal J, Xie G, Packard T, Laustsen A, Neidleman J, Georgiou K, et al. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunol. 2021;: pubmed publisher
  79. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  80. Lu H, Hsu H, Li C, Li S, Lin S, Shih C, et al. Hydrogen Sulfide Attenuates Aortic Remodeling in Aortic Dissection Associating with Moderated Inflammation and Oxidative Stress through a NO-Dependent Pathway. Antioxidants (Basel). 2021;10: pubmed publisher
  81. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  82. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  83. Zhang Z, Zhang N, Shi J, Dai C, Wu S, Jiao M, et al. Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration. Front Immunol. 2021;12:657803 pubmed publisher
  84. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  85. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed publisher
  86. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  87. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  88. Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed publisher
  89. Vemulapalli V, Chylek L, Erickson A, Pfeiffer A, Gabriel K, LaRochelle J, et al. Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling. elife. 2021;10: pubmed publisher
  90. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed publisher
  91. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  92. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  93. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021;184:1821-1835.e16 pubmed publisher
  94. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  95. Paul S, Pearlman A, Douglass J, Mog B, Hsiue E, Hwang M, et al. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13: pubmed publisher
  96. Hsiue E, Wright K, Douglass J, Hwang M, Mog B, Pearlman A, et al. Targeting a neoantigen derived from a common TP53 mutation. Science. 2021;371: pubmed publisher
  97. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  98. Fletcher R, Tong J, Risnik D, Leibowitz B, Wang Y, Concha Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40:2035-2050 pubmed publisher
  99. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed publisher
  100. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed publisher
  101. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
  102. Greferath U, Huynh M, Jobling A, Vessey K, Venables G, Surrao D, et al. Dorsal-Ventral Differences in Retinal Structure in the Pigmented Royal College of Surgeons Model of Retinal Degeneration. Front Cell Neurosci. 2020;14:553708 pubmed publisher
  103. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  104. Wang M, Murdoch C, Brewer A, Ivetic A, Evans P, Shah A, et al. Endothelial NADPH oxidase 4 protects against angiotensin II-induced cardiac fibrosis and inflammation. ESC Heart Fail. 2021;8:1427-1437 pubmed publisher
  105. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  106. Sharma N, Hans C. Interleukin 12p40 Deficiency Promotes Abdominal Aortic Aneurysm by Activating CCN2/MMP2 Pathways. J Am Heart Assoc. 2021;10:e017633 pubmed publisher
  107. Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644 pubmed publisher
  108. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  109. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  110. Chen C, Wang D, Yu Y, Zhao T, Min N, Wu Y, et al. Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell Death Dis. 2021;12:65 pubmed publisher
  111. Aslam M, Alemdehy M, Kwesi Maliepaard E, Muhaimin F, Caganova M, Pardieck I, et al. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. EMBO Rep. 2021;22:e51184 pubmed publisher
  112. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  113. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  114. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
  115. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  116. Abbate J, Macri F, Capparucci F, Iaria C, Briguglio G, Cicero L, et al. Administration of Protein Hydrolysates from Anchovy (Engraulis Encrasicolus) Waste for Twelve Weeks Decreases Metabolic Dysfunction-Associated Fatty Liver Disease Severity in ApoE-/-Mice. Animals (Basel). 2020;10: pubmed publisher
  117. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  118. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  119. Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. elife. 2020;9: pubmed publisher
  120. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  121. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  122. Kamali S, Rajendran R, Stadelmann C, Karnati S, Rajendran V, Giraldo Velasquez M, et al. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling. Brain Pathol. 2021;31:297-311 pubmed publisher
  123. Wang C, Weng M, Xia S, Zhang M, Chen C, Tang J, et al. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Cancer Sci. 2021;112:178-193 pubmed publisher
  124. Moreno Valladares M, Silva T, Garcés J, Sáenz Antoñanzas A, Moreno Cugnon L, Álvarez Satta M, et al. CD8+ T cells are present at low levels in the white matter with physiological and pathological aging. Aging (Albany NY). 2020;12:18928-18941 pubmed publisher
  125. Deeba E, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. BMC Res Notes. 2020;13:460 pubmed publisher
  126. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  127. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed publisher
  128. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89-94 pubmed publisher
  129. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed publisher
  130. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  131. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  132. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  133. Kim J, Lee J, Go H, Lim J, Oh J, Kim Y, et al. Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis. Arthritis Res Ther. 2020;22:173 pubmed publisher
  134. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  135. Asare Y, Koehncke J, Selle J, Simsekyilmaz S, Jankowski J, Shagdarsuren G, et al. Differential Role for Activating FcγRIII in Neointima Formation After Arterial Injury and Diet-Induced Chronic Atherosclerosis in Apolipoprotein E-Deficient Mice. Front Physiol. 2020;11:673 pubmed publisher
  136. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  137. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed publisher
  138. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  139. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  140. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  141. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  142. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  143. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  144. Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed publisher
  145. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  146. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  147. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  148. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed publisher
  149. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  150. Lubow J, Virgilio M, Merlino M, Collins D, Mashiba M, Peterson B, et al. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. elife. 2020;9: pubmed publisher
  151. Yazawa K, Nakamura F, Masukawa D, Sato S, Hiroshima Y, Yabushita Y, et al. Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancreatic Cancer. Transl Oncol. 2020;13:100746 pubmed publisher
  152. Minervina A, Pogorelyy M, Komech E, Karnaukhov V, Bacher P, Rosati E, et al. Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones. elife. 2020;9: pubmed publisher
  153. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  154. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  155. Yiu G, Chung S, Mollhoff I, Nguyen U, Thomasy S, Yoo J, et al. Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates. Mol Ther Methods Clin Dev. 2020;16:179-191 pubmed publisher
  156. Guo X, Kolpakov M, Hooshdaran B, Schappell W, Wang T, Eguchi S, et al. Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload. JACC Basic Transl Sci. 2020;5:69-83 pubmed publisher
  157. Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020;578:160-165 pubmed publisher
  158. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  159. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
  160. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed publisher
  161. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  162. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed publisher
  163. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  164. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  165. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  166. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  167. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed publisher
  168. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  169. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  170. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  171. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  172. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  173. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed publisher
  174. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  175. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  176. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  177. Götzke H, Kilisch M, Martínez Carranza M, Sograte Idrissi S, Rajavel A, Schlichthaerle T, et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun. 2019;10:4403 pubmed publisher
  178. Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430-433 pubmed publisher
  179. Fu D, Senouthai S, Wang J, You Y. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance. BMC Nephrol. 2019;20:350 pubmed publisher
  180. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  181. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  182. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  183. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  184. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  185. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  186. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  187. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  188. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  189. Brook A, Jenkins R, Clayton A, Kift Morgan A, Raby A, Shephard A, et al. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis. Sci Rep. 2019;9:10136 pubmed publisher
  190. Gehrig J, Venkatesh S, Chang H, Hibberd M, Kung V, Cheng J, et al. Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science. 2019;365: pubmed publisher
  191. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  192. Dulken B, Buckley M, Navarro Negredo P, Saligrama N, Cayrol R, Leeman D, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205-210 pubmed publisher
  193. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  194. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  195. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  196. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  197. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  198. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  199. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  200. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed publisher
  201. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  202. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed publisher
  203. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  204. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  205. Garcia Agudo L, Janova H, Sendler L, Arinrad S, Steixner A, Hassouna I, et al. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion. FASEB J. 2019;33:8634-8647 pubmed publisher
  206. Cirelli K, Carnathan D, Nogal B, Martin J, Rodriguez O, Upadhyay A, et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance. Cell. 2019;177:1153-1171.e28 pubmed publisher
  207. Del Duca E, Pavel A, Dubin C, Song T, Wallace E, Peng X, et al. Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals. J Invest Dermatol. 2019;139:2228-2232.e10 pubmed publisher
  208. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  209. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  210. Walens A, DiMarco A, Lupo R, Kroger B, Damrauer J, Alvarez J. CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. elife. 2019;8: pubmed publisher
  211. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  212. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  213. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  214. Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M, et al. IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019;129:1926-1939 pubmed publisher
  215. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  216. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  217. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  218. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  219. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  220. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed publisher
  221. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  222. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  223. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed publisher
  224. Franco L, Gadkari M, Howe K, Sun J, Kardava L, Kumar P, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med. 2019;216:384-406 pubmed publisher
  225. Taura M, Song E, Ho Y, Iwasaki A. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat. Proc Natl Acad Sci U S A. 2019;116:2282-2289 pubmed publisher
  226. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  227. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  228. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  229. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  230. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed publisher
  231. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  232. Tan H, Jegaskanda S, Juno J, Esterbauer R, Wong J, Kelly H, et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019;129:850-862 pubmed publisher
  233. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  234. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  235. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  236. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  237. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  238. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  239. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  240. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  241. Cai Y, Abdel Mohsen M, Tomescu C, Xue F, Wu G, Howell B, et al. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation. J Virol. 2019;93: pubmed publisher
  242. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  243. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  244. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  245. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  246. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  247. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed publisher
  248. Sanyal R, Pavel A, Glickman J, Chan T, Zheng X, Zhang N, et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol. 2019;122:99-110.e6 pubmed publisher
  249. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed publisher
  250. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed publisher
  251. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  252. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  253. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed publisher
  254. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  255. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  256. Fischer M, Bantug G, Dimeloe S, Gubser P, Burgener A, Grählert J, et al. Early effector maturation of naïve human CD8+ T cells requires mitochondrial biogenesis. Eur J Immunol. 2018;48:1632-1643 pubmed publisher
  257. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  258. Desimio M, Giuliani E, Ferraro A, Adorno G, Doria M. In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus. Front Immunol. 2018;9:1514 pubmed publisher
  259. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed publisher
  260. Zhao Y, Harrison D, Song Y, Ji J, Huang J, Hui E. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Cell Rep. 2018;24:379-390.e6 pubmed publisher
  261. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  262. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed publisher
  263. Pulikkan J, Hegde M, Ahmad H, Belaghzal H, Illendula A, Yu J, et al. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172-186.e21 pubmed publisher
  264. Yang C, Chiu L, Chang C, Chuang H, Tan T. Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation. FASEB J. 2018;:fj201800244RR pubmed publisher
  265. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  266. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  267. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  268. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  269. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  270. Maston L, Jones D, Giermakowska W, Resta T, Ramiro Diaz J, Howard T, et al. Interleukin-6 trans-signaling contributes to chronic hypoxia-induced pulmonary hypertension. Pulm Circ. 2018;8:2045894018780734 pubmed publisher
  271. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed publisher
  272. Kiani Z, Dupuy F, Bruneau J, Lebouché B, Zhang C, Jackson E, et al. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1. J Immunol. 2018;201:113-123 pubmed publisher
  273. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed publisher
  274. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  275. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  276. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  277. Foerster F, Boegel S, Heck R, Pickert G, R ssel N, Rosigkeit S, et al. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells. Oncoimmunology. 2018;7:e1409929 pubmed publisher
  278. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  279. Flores Villanueva P, Ganachari M, Guio H, Mejia J, Granados J. An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines. J Immunol. 2018;200:2965-2977 pubmed publisher
  280. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  281. Messlinger H, Sebald H, Heger L, Dudziak D, Bogdan C, Schleicher U. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites. Front Immunol. 2018;9:24 pubmed publisher
  282. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  283. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  284. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed publisher
  285. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed publisher
  286. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  287. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed publisher
  288. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  289. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  290. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  291. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed publisher
  292. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed publisher
  293. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  294. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed publisher
  295. Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557 pubmed publisher
  296. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  297. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  298. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  299. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  300. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed publisher
  301. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed publisher
  302. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  303. Jackson E, Zhang C, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 2017;12:e0185160 pubmed publisher
  304. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  305. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  306. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  307. Kruglova N, Meshkova T, Kopylov A, Mazurov D, Filatov A. Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP). PLoS ONE. 2017;12:e0182468 pubmed publisher
  308. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed publisher
  309. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  310. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  311. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  312. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  313. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed publisher
  314. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  315. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  316. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  317. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  318. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  319. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  320. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  321. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  322. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  323. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed publisher
  324. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed publisher
  325. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  326. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  327. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  328. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  329. Ito D, Childress M, Mason N, Winter A, O BRIEN T, Henson M, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res. 2015;4:42 pubmed publisher
  330. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed publisher
  331. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed publisher
  332. Bittner S, Knoll G, Ehrenschwender M. Death receptor 3 signaling enhances proliferation of human regulatory T cells. FEBS Lett. 2017;591:1187-1195 pubmed publisher
  333. Khodadoust M, Olsson N, Wagar L, Haabeth O, Chen B, Swaminathan K, et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. 2017;543:723-727 pubmed publisher
  334. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  335. VALLABHAJOSYULA P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan C, et al. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017;127:1375-1391 pubmed publisher
  336. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed publisher
  337. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  338. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  339. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  340. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed publisher
  341. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed publisher
  342. Perander M, Al Mahdi R, Jensen T, Nunn J, Kildalsen H, Johansen B, et al. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2. Sci Rep. 2017;7:43471 pubmed publisher
  343. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  344. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  345. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  346. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  347. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  348. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  349. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  350. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  351. Daniels B, Jujjavarapu H, Durrant D, Williams J, Green R, White J, et al. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest. 2017;127:843-856 pubmed publisher
  352. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed publisher
  353. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  354. Yamaguchi T, Sato H, Kato Itoh M, Goto T, Hara H, Sanbo M, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191-196 pubmed publisher
  355. Berghoff S, Gerndt N, Winchenbach J, Stumpf S, Hosang L, Odoardi F, et al. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun. 2017;8:14241 pubmed publisher
  356. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed publisher
  357. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  358. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  359. Halbrook C, Wen H, Ruggeri J, Takeuchi K, Zhang Y, di Magliano M, et al. Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cell Mol Gastroenterol Hepatol. 2017;3:99-118 pubmed publisher
  360. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  361. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  362. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed publisher
  363. Larabee C, Desai S, Agasing A, Georgescu C, Wren J, Axtell R, et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016;22:1503-1513 pubmed
  364. Zhang Y, Yu J, Grachtchouk V, Qin T, Lumeng C, Sartor M, et al. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer. Oncotarget. 2017;8:5761-5773 pubmed publisher
  365. Raap U, Gehring M, Kleiner S, Rüdrich U, Eiz Vesper B, Haas H, et al. Human basophils are a source of - and are differentially activated by - IL-31. Clin Exp Allergy. 2017;47:499-508 pubmed publisher
  366. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  367. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  368. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  369. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  370. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  371. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed publisher
  372. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  373. Villanueva Cabello T, Martinez Duncker I. Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy. J Vis Exp. 2016;: pubmed publisher
  374. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  375. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed publisher
  376. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  377. Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, et al. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017;91: pubmed publisher
  378. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  379. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  380. Weingartner E, Courneya J, Keegan A, Golding A. A novel method for assaying human regulatory T cell direct suppression of B cell effector function. J Immunol Methods. 2017;441:1-7 pubmed publisher
  381. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  382. Habiel D, Krepostman N, Lilly M, Cavassani K, Coelho A, Shibata T, et al. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma. Oncotarget. 2016;7:83514-83529 pubmed publisher
  383. Gil V, Bhagat G, Howell L, Zhang J, Kim C, Stengel S, et al. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice. Dis Model Mech. 2016;9:1483-1495 pubmed
  384. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  385. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  386. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed publisher
  387. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  388. Chung B, Guevel B, Reynolds G, Gupta Udatha D, Henriksen E, Stamataki Z, et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45-54 pubmed publisher
  389. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  390. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed publisher
  391. Holzlechner M, Strasser K, Zareva E, Steinhäuser L, Birnleitner H, Beer A, et al. In Situ Characterization of Tissue-Resident Immune Cells by MALDI Mass Spectrometry Imaging. J Proteome Res. 2017;16:65-76 pubmed publisher
  392. Osterburg A, Nelson R, Yaniv B, Foot R, Donica W, Nashu M, et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight. 2016;1:e87270 pubmed publisher
  393. Isitman G, Tremblay McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy J, et al. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. PLoS ONE. 2016;11:e0164517 pubmed publisher
  394. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  395. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  396. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  397. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  398. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  399. Milanovic M, Heise N, De Silva N, Anderson M, Silva K, Carette A, et al. Differential requirements for the canonical NF-?B transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol. 2017;95:261-271 pubmed publisher
  400. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  401. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  402. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  403. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  404. Rudemiller N, Patel M, Zhang J, Jeffs A, Karlovich N, Griffiths R, et al. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. Am J Pathol. 2016;186:2846-2856 pubmed publisher
  405. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  406. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  407. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  408. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  409. Nerdal P, Peters C, Oberg H, Zlatev H, Lettau M, Quabius E, et al. Butyrophilin 3A/CD277-Dependent Activation of Human ?? T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. J Immunol. 2016;197:3059-3068 pubmed
  410. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  411. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  412. Tang M, Reedquist K, Garcia S, Fernandez B, Codullo V, Vieira Sousa E, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016;55:2248-2259 pubmed
  413. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  414. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  415. Guillou L, Babataheri A, Saitakis M, Bohineust A, Dogniaux S, Hivroz C, et al. T-lymphocyte passive deformation is controlled by unfolding of membrane surface reservoirs. Mol Biol Cell. 2016;27:3574-3582 pubmed
  416. Wang L, Xu D, Qiao Z, Shen L, Dai H, Ji Y. Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncol Lett. 2016;12:2062-2064 pubmed
  417. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  418. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  419. Pageon S, Nicovich P, Mollazade M, Tabarin T, Gaus K. Clus-DoC: a combined cluster detection and colocalization analysis for single-molecule localization microscopy data. Mol Biol Cell. 2016;27:3627-3636 pubmed
  420. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334 pubmed publisher
  421. Pageon S, Tabarin T, Yamamoto Y, Ma Y, Nicovich P, Bridgeman J, et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proc Natl Acad Sci U S A. 2016;113:E5454-63 pubmed publisher
  422. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  423. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed publisher
  424. Guo X, Sun X, Hu D, Wang Y, Fujioka H, Vyas R, et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat Commun. 2016;7:12646 pubmed publisher
  425. Huynh L, Kusnadi A, Park S, Murata K, Park Min K, Ivashkiv L. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep. 2016;6:31959 pubmed publisher
  426. Chuang H, Chen Y, Hung W, Li J, Chen D, Lan J, et al. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget. 2016;7:57593-57605 pubmed publisher
  427. Inoue T, Griffin D, Huq R, Samuel E, Ruano S, Stinnett G, et al. Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016;29:1436-44 pubmed publisher
  428. Mercer F, Diala F, Chen Y, Molgora B, Ng S, Johnson P. Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis. PLoS Negl Trop Dis. 2016;10:e0004913 pubmed publisher
  429. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed publisher
  430. Abdullah C, Li Z, Wang X, Jin Z. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy. Int Immunopharmacol. 2016;39:251-264 pubmed publisher
  431. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  432. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  433. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  434. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  435. De S, Li D, Song S, Matta B, Barnes B. Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality. Sci Rep. 2016;6:31002 pubmed publisher
  436. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  437. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  438. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  439. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  440. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  441. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  442. Schweiger T, Berghoff A, Glogner C, Glueck O, Rajky O, Traxler D, et al. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis. 2016;33:727-39 pubmed publisher
  443. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  444. Fransén Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk A, et al. A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis. PLoS ONE. 2016;11:e0159850 pubmed publisher
  445. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  446. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  447. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  448. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  449. Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L, et al. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep. 2016;6:29353 pubmed publisher
  450. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  451. Sommer A, Fadler T, Dorfmeister E, Hoffmann A, Xiang W, Winner B, et al. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model. J Neuroinflammation. 2016;13:174 pubmed publisher
  452. Konkalmatt P, Asico L, Zhang Y, Yang Y, Drachenberg C, Zheng X, et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight. 2016;1: pubmed
  453. Mo A, Jackson S, Varma K, Carpino A, Giardina C, Devers T, et al. Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development. Mol Cancer Res. 2016;14:795-804 pubmed publisher
  454. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  455. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  456. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  457. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  458. Liu Y, Xia T, Jin C, Gu D, Yu J, Shi W, et al. FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer. Oncol Lett. 2016;11:3693-3701 pubmed
  459. Seumois G, Zapardiel Gonzalo J, White B, Singh D, Schulten V, Dillon M, et al. Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma. J Immunol. 2016;197:655-64 pubmed publisher
  460. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  461. Casella G, Garzetti L, Gatta A, Finardi A, Maiorino C, Ruffini F, et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J Neuroinflammation. 2016;13:139 pubmed publisher
  462. Ma Q, Garber H, Lu S, He H, Tallis E, Ding X, et al. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016;18:985-94 pubmed publisher
  463. Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, et al. Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors. Oncotarget. 2016;7:39256-39269 pubmed publisher
  464. Hahn S, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, et al. A key role of GARP in the immune suppressive tumor microenvironment. Oncotarget. 2016;7:42996-43009 pubmed publisher
  465. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  466. van Ree J, Nam H, Jeganathan K, Kanakkanthara A, van Deursen J. Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol. 2016;18:814-21 pubmed publisher
  467. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  468. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed publisher
  469. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  470. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  471. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  472. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed publisher
  473. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  474. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed publisher
  475. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  476. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed publisher
  477. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  478. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  479. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  480. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  481. Bolz M, Ruggli N, Borel N, Pluschke G, Ruf M. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model. PLoS Negl Trop Dis. 2016;10:e0004678 pubmed publisher
  482. Larabee C, Hu Y, Desai S, Georgescu C, Wren J, Axtell R, et al. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice. Mol Vis. 2016;22:332-41 pubmed
  483. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  484. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  485. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed publisher
  486. Blas Rus N, Bustos Morán E, Perez de Castro I, de Carcer G, Borroto A, Camafeita E, et al. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nat Commun. 2016;7:11389 pubmed publisher
  487. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  488. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  489. Kumar A, Abbas W, Colin L, Khan K, Bouchat S, Varin A, et al. Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep. 2016;6:24090 pubmed publisher
  490. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  491. Del Bel Belluz L, Guidi R, Pateras I, Levi L, Mihaljevic B, Rouf S, et al. The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection. PLoS Pathog. 2016;12:e1005528 pubmed publisher
  492. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed publisher
  493. Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed publisher
  494. Nakatsugawa M, Rahman M, Yamashita Y, Ochi T, Wnuk P, Tanaka S, et al. CD4(+) and CD8(+) TCR? repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep. 2016;6:23821 pubmed publisher
  495. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed publisher
  496. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  497. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  498. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed publisher
  499. O Rourke J, Bogdanik L, Yáñez A, Lall D, Wolf A, Muhammad A, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324-9 pubmed publisher
  500. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  501. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, et al. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS ONE. 2016;11:e0150411 pubmed publisher
  502. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  503. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  504. Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, et al. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016;5:e1025194 pubmed
  505. Heylmann D, Kaina B. The γH2AX DNA damage assay from a drop of blood. Sci Rep. 2016;6:22682 pubmed publisher
  506. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed publisher
  507. Frodermann V, Van Duijn J, van Puijvelde G, van Santbrink P, Lagraauw H, de Vries M, et al. Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages. J Intern Med. 2016;279:592-605 pubmed publisher
  508. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  509. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  510. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed publisher
  511. Singhal G, Fisher F, Chee M, Tan T, El Ouaamari A, Adams A, et al. Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas. PLoS ONE. 2016;11:e0148252 pubmed publisher
  512. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  513. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  514. Gibson Corley K, Boyden A, Leidinger M, Lambertz A, Ofori Amanfo G, Naumann P, et al. A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis. Peerj. 2016;4:e1600 pubmed publisher
  515. Garcia Bates T, Kim E, Concha Benavente F, Trivedi S, Mailliard R, Gambotto A, et al. Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1. J Immunol. 2016;196:2870-8 pubmed publisher
  516. Ha D, Carpenter L, Koutakis P, Swanson S, Zhu Z, Hanna M, et al. Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease. J Transl Med. 2016;14:39 pubmed publisher
  517. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  518. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed publisher
  519. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  520. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  521. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  522. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  523. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed publisher
  524. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  525. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  526. Kindy M, Yu J, Zhu H, Smith M, Gattoni Celli S. A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med. 2016;14:1 pubmed publisher
  527. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175-82 pubmed publisher
  528. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  529. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  530. Hesketh A, Maloney C, Behr C, Edelman M, Glick R, Al Abed Y, et al. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation. PLoS ONE. 2015;10:e0145197 pubmed publisher
  531. Karlsson H, Svensson E, Gigg C, Jarvius M, Olsson Strömberg U, Savoldo B, et al. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. PLoS ONE. 2015;10:e0144787 pubmed publisher
  532. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  533. Liu T, Weng S, Wang M, Huang W. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216-20 pubmed publisher
  534. Lee W, Richard J, Lichtfuss M, Smith A, Park J, Courter J, et al. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016;90:2021-30 pubmed publisher
  535. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  536. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  537. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed publisher
  538. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  539. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed publisher
  540. Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong R, Miller K, et al. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development. Cancer Discov. 2016;6:188-201 pubmed publisher
  541. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed publisher
  542. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  543. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  544. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed publisher
  545. Li L, Xu L, Yan J, Zhen Z, Ji Y, Liu C, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129 pubmed publisher
  546. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  547. Akhmetzyanova I, Drabczyk M, Neff C, Gibbert K, Dietze K, Werner T, et al. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog. 2015;11:e1005224 pubmed publisher
  548. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  549. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  550. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  551. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed publisher
  552. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  553. Covarrubias Pinto A, Moll P, Solís Maldonado M, Acuña A, Riveros A, Miró M, et al. Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease. Free Radic Biol Med. 2015;89:1085-96 pubmed publisher
  554. Martinez N, Agosto L, Qiu J, Mallory M, Gazzara M, Barash Y, et al. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation. Genes Dev. 2015;29:2054-66 pubmed publisher
  555. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  556. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  557. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631 pubmed publisher
  558. Cichocki F, Cooley S, Davis Z, DeFor T, Schlums H, Zhang B, et al. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia. 2016;30:456-63 pubmed publisher
  559. Murayama M, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6:8483 pubmed publisher
  560. Wawrzyniak M, Ochsner U, Wirz O, Wawrzyniak P, Van De Veen W, Akdis C, et al. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. Allergy. 2016;71:47-57 pubmed publisher
  561. Silacci M, Lembke W, Woods R, Attinger Toller I, Baenziger Tobler N, Batey S, et al. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. MAbs. 2016;8:141-9 pubmed publisher
  562. Bego M, Côté Ã, Cohen Ã. Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. J Vis Exp. 2015;: pubmed publisher
  563. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  564. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed publisher
  565. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  566. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  567. Ribera Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. 2015;28:1435-47 pubmed publisher
  568. Wang X, Zeng X, Yang B, Zhao S, Chen W, Guo X. Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model. Mol Med Rep. 2015;12:6775-81 pubmed publisher
  569. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed publisher
  570. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  571. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  572. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed publisher
  573. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  574. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  575. Zhang W, Smythe J, Frith E, Belfield H, Clarke S, Watt S, et al. An innovative method to generate a Good Manufacturing Practice-ready regulatory T-cell product from non-mobilized leukapheresis donors. Cytotherapy. 2015;17:1268-79 pubmed publisher
  576. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed publisher
  577. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  578. Klammt C, Novotná L, Li D, Wolf M, Blount A, Zhang K, et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol. 2015;16:961-9 pubmed publisher
  579. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  580. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  581. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed publisher
  582. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  583. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  584. Patyka M, Malamud D, Weissman D, Abrams W, Kurago Z. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS ONE. 2015;10:e0132942 pubmed publisher
  585. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  586. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed publisher
  587. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  588. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  589. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  590. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  591. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed publisher
  592. Cimini E, Agrati C, D Offizi G, Vlassi C, Casetti R, Sacchi A, et al. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 2015;10:e0129771 pubmed publisher
  593. Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen J, et al. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A. 2015;112:8070-5 pubmed publisher
  594. Fahlbusch F, Ruebner M, Huebner H, Volkert G, Bartunik H, Winterfeld I, et al. Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol. 2015;144:281-91 pubmed publisher
  595. Shields E, Lam C, Cox A, Rankin M, Van Winkle T, Hess R, et al. Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS ONE. 2015;10:e0129809 pubmed publisher
  596. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  597. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  598. Soares A, Müller T, Chege G, Williamson A, Burgers W. Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV. Vaccine. 2015;33:3435-9 pubmed publisher
  599. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  600. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed publisher
  601. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  602. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed publisher
  603. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  604. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  605. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  606. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  607. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed publisher
  608. Liao J, Ovenell K, Curtis E, Cecil D, Koehnlein M, Rastetter L, et al. Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer. J Immunother Cancer. 2015;3:16 pubmed publisher
  609. Oberg H, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, et al. γδ T cell activation by bispecific antibodies. Cell Immunol. 2015;296:41-9 pubmed publisher
  610. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed publisher
  611. Vettermann C, Victor H, Sun Y, Plewa C, Gupta S. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells. J Immunol Methods. 2015;424:14-9 pubmed publisher
  612. Campia I, Buondonno I, Castella B, Rolando B, Kopecka J, Gazzano E, et al. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells. PLoS ONE. 2015;10:e0126159 pubmed publisher
  613. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed publisher
  614. Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570 pubmed
  615. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  616. Bhat N, Kshirsagar M, Bieber M, Teng N. IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies. Immunol Invest. 2015;44:400-10 pubmed publisher
  617. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  618. Li Y, Kang G, Duan L, Lu W, Katze M, Lewis M, et al. SIV Infection of Lung Macrophages. PLoS ONE. 2015;10:e0125500 pubmed publisher
  619. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  620. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  621. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  622. Rogers R, Eastham Anderson J, DeVoss J, Lesch J, Yan D, Xu M, et al. Image Analysis-Based Approaches for Scoring Mouse Models of Colitis. Vet Pathol. 2016;53:200-10 pubmed publisher
  623. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  624. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  625. Maiwald S, Motazacker M, van Capelleveen J, Sivapalaratnam S, van der Wal A, van der Loos C, et al. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. Eur J Hum Genet. 2016;24:86-91 pubmed publisher
  626. Heinzmann D, Bangert A, Müller A, von Ungern Sternberg S, Emschermann F, Schönberger T, et al. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis. PLoS ONE. 2015;10:e0124606 pubmed publisher
  627. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed publisher
  628. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  629. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed publisher
  630. Katz S, Burga R, McCormack E, Wang L, Mooring W, Point G, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. Clin Cancer Res. 2015;21:3149-59 pubmed publisher
  631. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  632. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed publisher
  633. Lougaris V, Ravelli A, Villanacci V, Salemme M, Soresina A, Fuoti M, et al. Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency. Dig Dis Sci. 2015;60:2384-9 pubmed publisher
  634. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  635. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  636. McClintock S, Warner R, Ali S, Chekuri A, Dame M, Attili D, et al. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models. Cancer Biol Ther. 2015;16:724-32 pubmed publisher
  637. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  638. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  639. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  640. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  641. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  642. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  643. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  644. Nambiar J, Clarke A, Shim D, Mabon D, Tian C, Windloch K, et al. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs. 2015;7:638-50 pubmed publisher
  645. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed publisher
  646. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed publisher
  647. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  648. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  649. van der Waart A, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunol Immunother. 2015;64:645-54 pubmed publisher
  650. Rodriguez J, Marchicio J, López M, Ziblat A, Elias F, Fló J, et al. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells. PLoS ONE. 2015;10:e0117484 pubmed publisher
  651. Boutard B, Vankerckhove S, Markine Goriaynoff N, Sarlet M, Desmecht D, McFadden G, et al. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS ONE. 2015;10:e0118806 pubmed publisher
  652. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  653. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed publisher
  654. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  655. Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, et al. Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015;6:6351 pubmed publisher
  656. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  657. Sakitani E, Nonaka M, Shibata N, Furukawa T, Yoshihara T. Increased expression of thymic stromal lymphopoietin and its receptor in Kimura's disease. ORL J Otorhinolaryngol Relat Spec. 2015;77:44-54 pubmed publisher
  658. Kwun J, Page E, Hong J, GIBBY A, Yoon J, Farris A, et al. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. Am J Transplant. 2015;15:815-22 pubmed publisher
  659. Comrie W, Babich A, Burkhardt J. F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J Cell Biol. 2015;208:475-91 pubmed publisher
  660. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed publisher
  661. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  662. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  663. Wagner R, Luciani F, Cario André M, Rubod A, Petit V, Benzekri L, et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015;135:1810-1819 pubmed publisher
  664. Hill E, Ng T, Burton B, Oakley C, Malik K, Wraith D. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015;45:1103-15 pubmed publisher
  665. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed publisher
  666. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  667. Zhao H, Bauzon F, Bi E, Yu J, Fu H, Lu Z, et al. Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age. J Biol Chem. 2015;290:5797-809 pubmed publisher
  668. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed publisher
  669. Weston C, Shepherd E, Claridge L, Rantakari P, Curbishley S, Tomlinson J, et al. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J Clin Invest. 2015;125:501-20 pubmed publisher
  670. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed publisher
  671. Bende R, Slot L, Hoogeboom R, Wormhoudt T, Adeoye A, Guikema J, et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheumatol. 2015;67:1074-83 pubmed publisher
  672. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  673. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  674. Caramalho I, Nunes Silva V, Pires A, Mota C, Pinto A, Nunes Cabaço H, et al. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus. J Autoimmun. 2015;56:98-110 pubmed publisher
  675. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  676. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  677. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  678. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  679. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  680. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72:131-9 pubmed publisher
  681. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  682. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  683. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  684. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed publisher
  685. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed publisher
  686. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  687. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  688. Makowski S, Wang Z, Pomerantz J. A protease-independent function for SPPL3 in NFAT activation. Mol Cell Biol. 2015;35:451-67 pubmed publisher
  689. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  690. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  691. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  692. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  693. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  694. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  695. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed publisher
  696. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed publisher
  697. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed publisher
  698. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  699. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  700. Novinger L, Ashikaga T, Krag D. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer. Cancer Immunol Immunother. 2015;64:29-39 pubmed publisher
  701. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  702. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  703. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  704. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed publisher
  705. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  706. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  707. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  708. Landy J, Al Hassi H, Ronde E, English N, Mann E, Bernardo D, et al. Innate immune factors in the development and maintenance of pouchitis. Inflamm Bowel Dis. 2014;20:1942-9 pubmed publisher
  709. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed publisher
  710. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  711. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  712. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  713. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed publisher
  714. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  715. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher
  716. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  717. Ramirez L, Arango T, Thompson E, Naji M, Tebas P, Boyer J. High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART. J Leukoc Biol. 2014;96:1055-63 pubmed publisher
  718. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  719. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed publisher
  720. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  721. Boyd Tressler A, Penuela S, Laird D, Dubyak G. Chemotherapeutic drugs induce ATP release via caspase-gated pannexin-1 channels and a caspase/pannexin-1-independent mechanism. J Biol Chem. 2014;289:27246-63 pubmed publisher
  722. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  723. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  724. Laurent A, Bindslev N, Johansson B, Berg L. Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of ?? T cells in synovial fluid from patients with arthritis. PLoS ONE. 2014;9:e103683 pubmed publisher
  725. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  726. de Bock L, Somers K, Fraussen J, Hendriks J, van Horssen J, Rouwette M, et al. Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis. J Immunol. 2014;193:2147-56 pubmed publisher
  727. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  728. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  729. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  730. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  731. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  732. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  733. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed publisher
  734. Kawasaki N, Rillahan C, Cheng T, Van Rhijn I, Macauley M, Moody D, et al. Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol. 2014;193:1560-6 pubmed publisher
  735. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed publisher
  736. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed publisher
  737. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed publisher
  738. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed publisher
  739. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed publisher
  740. Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014;85:1386-95 pubmed publisher
  741. Little J, Bleedorn J, Sutherland B, Sullivan R, Kalscheur V, Ramaker M, et al. Arthroscopic assessment of stifle synovitis in dogs with cranial cruciate ligament rupture. PLoS ONE. 2014;9:e97329 pubmed publisher
  742. Chan W, Suwannasaen D, Throm R, Li Y, Eldridge P, Houston J, et al. Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia. 2015;29:387-95 pubmed publisher
  743. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  744. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  745. Adamski M, Li Y, Wagner E, Yu H, Seales Bailey C, Durkin H, et al. Pre-existing hypertension dominates ??T cell reduction in human ischemic stroke. PLoS ONE. 2014;9:e97755 pubmed publisher
  746. Foster A, Baliwag J, Chen C, Guzman A, Stoll S, Gudjonsson J, et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol. 2014;192:6053-61 pubmed publisher
  747. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  748. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  749. Jakobsson T, Vedin L, Hassan T, Venteclef N, Greco D, D AMATO M, et al. The oxysterol receptor LXR? protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol. 2014;7:1416-28 pubmed publisher
  750. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  751. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  752. Schirmer L, Srivastava R, Kalluri S, Böttinger S, Herwerth M, Carassiti D, et al. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. Ann Neurol. 2014;75:810-28 pubmed publisher
  753. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  754. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  755. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed publisher
  756. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170:816-23 pubmed publisher
  757. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner J, Cohen N, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2014;9:e94699 pubmed publisher
  758. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  759. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  760. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  761. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  762. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed publisher
  763. Gros A, Robbins P, Yao X, Li Y, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific CD8? tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124:2246-59 pubmed publisher
  764. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  765. Li Z, Abdullah C, Jin Z. Inhibition of PKC-? preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy. Br J Pharmacol. 2014;171:2913-24 pubmed publisher
  766. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  767. Witsch T, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, et al. Transglutaminase 2: a new player in bronchopulmonary dysplasia?. Eur Respir J. 2014;44:109-21 pubmed publisher
  768. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  769. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed publisher
  770. Rodriguez A, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu A, et al. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus. Cell Immunol. 2014;288:24-30 pubmed publisher
  771. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  772. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  773. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed publisher
  774. Lyngaa R, Pedersen N, Schrama D, Thrue C, Ibrani D, Met O, et al. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res. 2014;20:1768-78 pubmed publisher
  775. Wertheimer A, Bennett M, Park B, Uhrlaub J, Martinez C, Pulko V, et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014;192:2143-55 pubmed publisher
  776. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  777. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  778. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed publisher
  779. Sakamoto T, Kobayashi M, Tada K, Shinohara M, Io K, Nagata K, et al. CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1. PLoS ONE. 2014;9:e85762 pubmed publisher
  780. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed publisher
  781. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed publisher
  782. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed publisher
  783. Wong E, Akilimali N, Govender P, Sullivan Z, Cosgrove C, Pillay M, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE. 2013;8:e83474 pubmed publisher
  784. Koppensteiner H, H hne K, Gondim M, Gobert F, Widder M, Gundlach S, et al. Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology. 2014;11:1 pubmed publisher
  785. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  786. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed publisher
  787. Rodriguez M, Loyd C, Ding X, Karim A, MCDONALD D, Canaday D, et al. Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE. 2013;8:e80938 pubmed publisher
  788. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed publisher
  789. Emara M, Turner A, Allalunis Turner J. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol. 2014;44:514-20 pubmed publisher
  790. Rapetti L, Chavele K, Evans C, Ehrenstein M. B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis. 2015;74:294-302 pubmed publisher
  791. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  792. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, et al. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion. 2014;54:1305-16 pubmed publisher
  793. Turcotte S, Gros A, Tran E, Lee C, Wunderlich J, Robbins P, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-43 pubmed publisher
  794. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  795. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed publisher
  796. Luan G, Gao Q, Guan Y, Zhai F, Zhou J, Liu C, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol. 2013;72:1000-8 pubmed publisher
  797. Lin G, Field J, Yu J, Ken R, Neuberg D, Nathan D, et al. NF-?B is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS ONE. 2013;8:e74664 pubmed publisher
  798. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  799. Saghafian Hedengren S, Sohlberg E, Theorell J, Carvalho Queiroz C, Nagy N, Persson J, et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol. 2013;87:13446-55 pubmed publisher
  800. Puentes F, van der Star B, Victor M, Kipp M, Beyer C, Peferoen Baert R, et al. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013;10:118 pubmed publisher
  801. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  802. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  803. Li H, Pauza C. Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology. 2013;10:60 pubmed publisher
  804. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed publisher
  805. Dintwe O, Day C, Smit E, Nemes E, Gray C, Tameris M, et al. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function. Eur J Immunol. 2013;43:2409-20 pubmed publisher
  806. Zhou D, Tan R, Lin L, Zhou L, Liu Y. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int. 2013;84:509-20 pubmed publisher
  807. Fischer M, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136:1799-815 pubmed publisher
  808. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  809. Kvarnung M, Nilsson D, Lindstrand A, Korenke G, Chiang S, Blennow E, et al. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet. 2013;50:521-8 pubmed publisher
  810. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed publisher
  811. Jacobs S, Plessers J, Pinxteren J, Roobrouck V, Verfaillie C, Van Gool S. Mutual interaction between human multipotent adult progenitor cells and NK cells. Cell Transplant. 2014;23:1099-110 pubmed publisher
  812. Brana C, Frossard M, Pescini Gobert R, Martinier N, Boschert U, Seabrook T. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2014;40:564-78 pubmed publisher
  813. Paster W, Brockmeyer C, Fu G, Simister P, de Wet B, Martinez Riaño A, et al. GRB2-mediated recruitment of THEMIS to LAT is essential for thymocyte development. J Immunol. 2013;190:3749-56 pubmed publisher
  814. Introini A, Vanpouille C, Lisco A, Grivel J, Margolis L. Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo. PLoS Pathog. 2013;9:e1003148 pubmed publisher
  815. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  816. Yan R, Zhong W, Zhu Y, Zhang X. Trichosanthin-stimulated dendritic cells induce a type 2 helper T lymphocyte response through the OX40 ligand. J Investig Allergol Clin Immunol. 2012;22:491-500 pubmed
  817. Field J, Lin G, Okam M, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329-34 pubmed publisher
  818. Muñoz Ruiz M, Pérez Flores V, Garcillán B, Guardo A, Mazariegos M, Takada H, et al. Human CD3?, but not CD3?, haploinsufficiency differentially impairs ?? versus ?? surface TCR expression. BMC Immunol. 2013;14:3 pubmed publisher
  819. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed publisher
  820. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  821. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  822. O CONNOR T, Frei N, Sponarova J, Schwarz P, Heikenwalder M, Aguzzi A. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 2012;8:e1002867 pubmed publisher
  823. Sharma S, Pichichero M. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281-91 pubmed publisher
  824. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  825. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  826. Fong B, JIN R, Wang X, Safaee M, Lisiero D, Yang I, et al. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS ONE. 2012;7:e32614 pubmed publisher
  827. Frahm M, Picking R, Kuruc J, McGee K, Gay C, Eron J, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol. 2012;188:4289-96 pubmed publisher
  828. Gilroy C, Forzán M, Drew A, Vernau W. Eosinophilia in a cat with acute leukemia. Can Vet J. 2011;52:1004-8 pubmed
  829. Zeng M, Southern P, Reilly C, Beilman G, Chipman J, Schacker T, et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012;8:e1002437 pubmed publisher
  830. Schneckenleithner C, Bago Horvath Z, Dolznig H, Neugebauer N, Kollmann K, Kolbe T, et al. Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget. 2011;2:1043-54 pubmed
  831. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed publisher
  832. Meeths M, Chiang S, Wood S, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783-93 pubmed publisher
  833. Magrini E, Szabo I, Doni A, Cibella J, Viola A. Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12. PLoS ONE. 2011;6:e22482 pubmed publisher
  834. Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol. 2012;43:209-15 pubmed publisher
  835. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  836. Gall A, Horowitz A, Joof H, Natividad A, Tetteh K, Riley E, et al. Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Front Microbiol. 2011;2:10 pubmed publisher
  837. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  838. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  839. Mamedov I, Britanova O, Bolotin D, Chkalina A, Staroverov D, Zvyagin I, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med. 2011;3:201-7 pubmed publisher
  840. Kuzin I, Sun H, Moshkani S, Feng C, Mantalaris A, Wu J, et al. Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor. Biotechnol Bioeng. 2011;108:1430-40 pubmed publisher
  841. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, Park J, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol. 2011;186:2106-16 pubmed publisher
  842. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed publisher
  843. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  844. Reuwer A, van Eijk M, Houttuijn Bloemendaal F, van der Loos C, Claessen N, Teeling P, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?. J Endocrinol. 2011;208:107-17 pubmed publisher
  845. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed publisher
  846. Horowitz A, Behrens R, Okell L, Fooks A, Riley E. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol. 2010;185:2808-18 pubmed publisher
  847. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  848. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed publisher
  849. Zhou J, Belov L, Huang P, Shin J, Solomon M, Chapuis P, et al. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. J Immunol Methods. 2010;355:40-51 pubmed publisher
  850. Hunter P, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum. 2010;62:896-907 pubmed publisher
  851. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed publisher
  852. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19:317-22 pubmed publisher
  853. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  854. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed publisher
  855. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  856. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed publisher
  857. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  858. Richardson M, Carroll R, Stremlau M, Korokhov N, Humeau L, Silvestri G, et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol. 2008;82:11117-28 pubmed publisher
  859. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed publisher
  860. Lunemann J, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181:991-1000 pubmed
  861. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed publisher
  862. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  863. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  864. Muniz J, McCauley L, Scherer J, Lasarev M, Koshy M, Kow Y, et al. Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study. Toxicol Appl Pharmacol. 2008;227:97-107 pubmed
  865. Sangiolo D, Lesnikova M, Nash R, Jensen M, Nikitine A, Kiem H, et al. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Gene Ther. 2007;14:1549-54 pubmed
  866. Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-7 pubmed
  867. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  868. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  869. Estefanía E, Flores R, Gómez Lozano N, Aguilar H, Lopez Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol. 2007;178:4402-10 pubmed
  870. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  871. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  872. Clarke S, Betts G, Plant A, Wright K, El Shanawany T, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129 pubmed
  873. Xin K, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, et al. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol. 2006;80:11899-910 pubmed
  874. Hoves S, Krause S, Schutz C, Halbritter D, Scholmerich J, Herfarth H, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol. 2006;177:2691-8 pubmed
  875. Quiroga M, Pasquinelli V, Martinez G, Jurado J, Zorrilla L, Musella R, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74 pubmed
  876. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  877. Barsov E, Andersen H, Coalter V, Carrington M, Lifson J, Ott D. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett. 2006;105:26-37 pubmed
  878. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  879. Schaap A, Fortin J, Sommer M, Zerboni L, Stamatis S, Ku C, et al. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J Virol. 2005;79:12921-33 pubmed
  880. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  881. Tas S, Quartier P, Botto M, Fossati Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis. 2006;65:216-21 pubmed
  882. Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoe K, et al. Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod. 2005;11:451-7 pubmed
  883. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  884. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  885. Stütz A, Graf P, Beinhauer B, Hammerschmid F, Neumann C, Woisetschläger M, et al. CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL-4. Eur J Immunol. 2005;35:575-83 pubmed
  886. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  887. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173:6000-8 pubmed
  888. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  889. Bonanno G, Perillo A, Rutella S, De Ritis D, Mariotti A, Marone M, et al. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion. 2004;44:1087-97 pubmed
  890. Asin S, Fanger M, Wildt Perinic D, Ware P, Wira C, Howell A. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004;190:236-45 pubmed
  891. Yamada H, Shimada S, Kato E, Morikawa M, Iwabuchi K, Kishi R, et al. Decrease in a specific killer cell immunoglobulin-like receptor on peripheral natural killer cells in women with recurrent spontaneous abortion of unexplained etiology. Am J Reprod Immunol. 2004;51:241-7 pubmed
  892. Beinhauer B, McBride J, Graf P, Pursch E, Bongers M, Rogy M, et al. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol. 2004;34:74-80 pubmed
  893. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  894. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  895. Tjernlund A, Fleener Z, Behbahani H, Connick E, Sonnerborg A, Broström C, et al. Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells. AIDS. 2003;17:1303-10 pubmed
  896. Rahimi K, Maerz H, Zotz R, Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry B Clin Cytom. 2003;53:63-9 pubmed
  897. Rouard H, Leon A, De Reys S, Taylor L, Logan J, Marquet J, et al. A closed and single-use system for monocyte enrichment: potential for dendritic cell generation for clinical applications. Transfusion. 2003;43:481-7 pubmed
  898. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261-8 pubmed
  899. Dekel B, Burakova T, Arditti F, Reich Zeliger S, Milstein O, Aviel Ronen S, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med. 2003;9:53-60 pubmed
  900. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  901. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  902. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  903. Thompson S, Luyrink L, Graham T, Tsoras M, Ryan M, Passo M, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001;166:6899-906 pubmed
  904. Telford W, Moss M, Morseman J, Allnutt F. Cryptomonad algal phycobiliproteins as fluorochromes for extracellular and intracellular antigen detection by flow cytometry. Cytometry. 2001;44:16-23 pubmed
  905. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  906. Miller A, Kraiem Z, Sobel E, Lider O, Lahat N. Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix. Thyroid. 2000;10:945-50 pubmed
  907. Lafont B, Gloeckler L, D Hautcourt J, Gut J, Aubertin A. One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry. Cytometry. 2000;41:193-202 pubmed
  908. Kappelmayer J, Gratama J, Karászi E, Menendez P, Ciudad J, Rivas R, et al. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods. 2000;242:53-65 pubmed
  909. Graziani Bowering G, Filion L. Down regulation of CD4 expression following isolation and culture of human monocytes. Clin Diagn Lab Immunol. 2000;7:182-91 pubmed
  910. Martín Henao G, Picon M, Amill B, Querol S, Gonzalez J, Martinez C, et al. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion. 2000;40:35-43 pubmed
  911. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  912. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  913. Paz Miguel J, Flores R, Sanchez Velasco P, Ocejo Vinyals G, Escribano de Diego J, López de Rego J, et al. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J Immunol. 1999;163:5399-410 pubmed
  914. Cron R, Bort S, Wang Y, Brunvand M, Lewis D. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. J Immunol. 1999;162:860-70 pubmed
  915. Kim C, Pelus L, White J, Applebaum E, Johanson K, Broxmeyer H. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-24 pubmed
  916. Verhasselt B, De Smedt M, Verhelst R, Naessens E, Plum J. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood. 1998;91:431-40 pubmed
  917. Basch R, Quito F, Beh J, Hirst J. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. Stem Cells. 1997;15:314-23 pubmed
  918. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed
  919. Borst J, Alexander S, Elder J, Terhorst C. The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem. 1983;258:5135-41 pubmed
  920. Furley A, Mizutani S, Weilbaecher K, Dhaliwal H, Ford A, Chan L, et al. Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex. Cell. 1986;46:75-87 pubmed
  921. Gold D, Puck J, Pettey C, Cho M, Coligan J, Woody J, et al. Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature. 1986;321:431-4 pubmed